The transcription factor p53: Not a repressor, solely an activator

References

• Lane DP. Benchimol S. p53: oncogene or anti-oncogene? Genes Dev 1990; 4:1-8; PMID:2137806
   PubMed Web of Science ®Google Scholar
• Levine AJ, Oren M. The first 30 years of p53: growing ever more complex. Nat Rev Cancer 2009; 9:749-58; http://dx.doi.org/10.1038/nrc2723; PMID:19776744
   PubMed Web of Science ®Google Scholar
• Ko LJ, Prives C. p53: puzzle and paradigm. Genes Dev 1996; 10:1054-72; PMID:8654922
   PubMed Web of Science ®Google Scholar
• Menendez D, Inga A, Resnick MA. The expanding universe of p53 targets. Nat Rev Cancer 2009; 9:724-37; PMID:19776742; http://dx.doi.org/10.1038/nrc2730
   PubMed Web of Science ®Google Scholar
• Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, Shahab A, Yong HC, Fu Y, Weng Z, et al. A global map of p53 transcription-factor binding sites in the human genome. Cell 2006; 124:207-19; PMID:16413492
   PubMed Web of Science ®Google Scholar
• Smeenk L, van Heeringen SJ, Koeppel M, Gilbert B, Janssen-Megens E, Stunnenberg HG, Lohrum M. Role of p53 serine 46 in p53 target gene regulation. PLoS One 2011; 6(3):e17574; PMID:21394211; http://dx.doi.org/10.1371/journal.pone.0017574
   PubMed Web of Science ®Google Scholar
• Nikulenkov F, Spinnler C, Li H, Tonelli C, Shi Y, Turunen M, Kivioja T, Ignatiev I, Kel A, Taipale J, et al. Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis. Cell Death Differ 2012; 19:1992-2002; PMID:22790872; http://dx.doi.org/10.1038/cdd.2012.89
   PubMed Web of Science ®Google Scholar
• Menendez D, Nguyen TA, Freudenberg JM, Mathew VJ, Anderson CW, Jothi R, Resnick MA. Diverse stresses dramatically alter genome-wide p53 binding and transactivation landscape in human cancer cells. Nucleic Acids Res 2013; 41:7286-301; http://dx.doi.org/10.1093/nar/gkt504
   PubMed Web of Science ®Google Scholar
• Schlereth K, Heyl C, Krampitz AM, Mernberger M, Finkernagel F, Scharfe M, Jarek M, Leich E, Rosenwald A, Stiewe T. Characterization of the p53 cistrome - DNA binding cooperativity dissects p53‘s tumor suppressor functions. Plos Genetics 2013; 9(8):e1003726; PMID:23966881; http://dx.doi.org/10.1371/journal.pgen.1003726
   PubMed Web of Science ®Google Scholar
• Graur D, Zheng Y, Price N, Azevedo RB, Zufall RA, Elhaik E. On the immortality of television sets: ``function'' in the human genome according to the evolution-free gospel of ENCODE. Genome Biol Evol 2013; 5:578-90; PMID:23431001; http://dx.doi.org/10.1093/gbe/evt028
   PubMed Web of Science ®Google Scholar
• Ioannidis JP. Why most published research findings are false. PLoS Med 2005; 2:e124; PMID:16060722
   PubMed Web of Science ®Google Scholar
• Fanelli D. Negative results are disappearing from most disciplines and countries. Scientometrics 2012; 90:891-904; http://dx.doi.org/10.1007/s11192-011-0494-7
   Web of Science ®Google Scholar
• Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008; 9:402-12; PMID:18431400; http://dx.doi.org/10.1038/nrm2395
   PubMed Web of Science ®Google Scholar
• Vousden KH, Prives C. Blinded by the Light: The Growing Complexity of p53. Cell 2009; 137:413-31; PMID:19410540; http://dx.doi.org/10.1016/j.cell.2009.04.037
   PubMed Web of Science ®Google Scholar
• Beckerman R, Prives C. Transcriptional regulation by p53. Cold Spring Harb Perspect Biol 2010; 2:a000935; PMID:20679336; http://dx.doi.org/10.1101/cshperspect.a000935
   PubMed Web of Science ®Google Scholar
• Böhlig L, Rother K. One function–multiple mechanisms: the manifold activities of p53 as a transcriptional repressor. J Biomed Biotechnol 2011; 2011:464916; PMID:21436991; http://dx.doi.org/10.1155/2011/464916
   PubMedGoogle Scholar
• Rinn JL, Huarte M. To repress or not to repress: this is the guardian's question. Trends Cell Biol 2011; 21:344-53; PMID:21601459; http://dx.doi.org/10.1016/j.tcb.2011.04.002
   PubMed Web of Science ®Google Scholar
• Leek JT, Scharpf RB, Bravo HC, Simcha D, Langmead B, Johnson WE, Geman D, Baggerly K, Irizarry RA. Tackling the widespread and critical impact of batch effects in high-throughput data. Nat Rev Genet 2010; 11 733-9; PMID:20838408; http://dx.doi.org/10.1038/nrg2825
   PubMed Web of Science ®Google Scholar
• Böhlig L, Friedrich M, Engeland K. p53 activates the PANK1miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins. Nucleic Acids Res 2011; 39:440-53; PMID:20833636; http://dx.doi.org/10.1093/nar/gkq796
   PubMed Web of Science ®Google Scholar
• Rashi-Elkeles S, Elkon R, Shavit S, Lerenthal Y, Linhart C, Kupershtein A, Amariglio N, Rechavi G, Shamir R, Shiloh Y. Transcriptional modulation induced by ionizing radiation: p53 remains a central player. Molecular Oncology 2011; 5:336-48; PMID:21795128; http://dx.doi.org/10.1016/j.molonc.2011.06.004
   PubMed Web of Science ®Google Scholar
• Rozenblatt-Rosen O, Deo RC, Padi M, Adelmant G, Calderwood MA, Rolland T, Grace M, Dricot A, Askenazi M, Tavares M, et al. Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. Nature 2012; 487:491-5; PMID:22810586; http://dx.doi.org/10.1038/nature11288
   PubMed Web of Science ®Google Scholar
• Kracikova M, Akiri G, George A, Sachidanandam R, Aaronson SA. A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis. Cell Death and Differentiation 2013; 20:576-88; PMID:23306555; http://dx.doi.org/10.1038/cdd.2012.155
   PubMed Web of Science ®Google Scholar
• Goldstein I, Ezra O, Rivlin N, Molchadsky A, Madar S, Goldfinger N, Rotter V. p53 a novel regulator of lipid metabolism pathways. J Hepatol 2012; 56:656-62; PMID:22037227; http://dx.doi.org/10.1016/j.jhep.2011.08.022
   PubMed Web of Science ®Google Scholar
• Smeenk L, van Heeringen SJ, Koeppel M, van Driel MA, Bartels SJ, Akkers RC, Denissov S, Stunnenberg HG, Lohrum M. Characterization of genome-wide p53-binding sites upon stress response. Nucleic Acids Res 2008; 36:3639-54; PMID:18474530; http://dx.doi.org/10.1093/nar/gkn232
   PubMed Web of Science ®Google Scholar
• Botcheva K, McCorkle SR, McCombie WR, Dunn JJ, Anderson CW. Distinct p53 genomic binding patterns in normal and cancer-derived human cells. Cell Cycle 2011; 10:4237-49; PMID:22127205; http://dx.doi.org/10.4161/cc.10.24.18383
   PubMed Web of Science ®Google Scholar
• Kenzelmann BD, Spano Mello S, Bieging KT, Jiang D, Dusek RL, Brady CA, Sidow A, Attardi LD. Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses. Genes Dev 2013; 27:1016-31; PMID:23651856; http://dx.doi.org/10.1101/gad.212282.112
   PubMed Web of Science ®Google Scholar
• Rashi-Elkeles S, Warnatz HJ, Elkon R>, Kupershtein A, Chobod Y, Paz A, Amstislavskiy V, Sultan M, Safer H, Nietfeld W, et al. Parallel profiling of the transcriptome cistrome and epigenome in the cellular response to ionizing radiation. Sci Signal 2014; 7:rs3; PMID:24825921; http://dx.doi.org/10.1126/scisignal.2005032
   PubMed Web of Science ®Google Scholar
• (a) Allen MA, Andrysik Z, Dengler VL, Mellert HS, Guarnieri A, Freeman JA, Sullivan KD, Galbraith MD, Luo X, Kraus WL, et al. Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms. Elife 2014; 3:e02200; PMID:24867637; http://dx.doi.org/10.7554/eLife.02200; (b) Janky R, Verfaillie A, Imrichová H, Van de Sande B, Standaert L, et al. iRegulon: From a gene list to a gene regulatory network using large motif and track collections. PLoS Comput Biol 2014; 10(7):e1003731; PMID:25058159; http://dx.doi.org/10.1371/journal.pcbi.100373
   PubMed Web of Science ®Google Scholar
• Mathieu MC, Lapierre I, Brault K, Raymond M. Aromatic hydrocarbon receptor (AhR)center dot AhR nuclear translocator- and p53-mediated induction of the murine multidrug resistance mdr1 gene by 3-methylcholanthrene and benzo(a)pyrene in hepatoma cells. J Biol Chem 2001; 276:4819-27; PMID:11096091
   PubMed Web of Science ®Google Scholar
• Comer KA, Dennis PA, Armstrong L, Catino JJ, Kastan MB, Kumar CC. Human smooth muscle alpha-actin gene is a transcriptional target of the p53 tumor suppressor protein. Oncogene 1998; 16:1299-1308; PMID:9546431
   PubMed Web of Science ®Google Scholar
• Kawase T, Ichikawa H, Ohta T, Nozaki N, Tashiro F, Ohki R, Taya Y. p53 target gene AEN is a nuclear exonuclease required for p53-dependent apoptosis. Oncogene 2008; 27:3797-810; PMID:18264133; http://dx.doi.org/10.1038/onc.2008.32
   PubMed Web of Science ®Google Scholar
• Pierzchalski P, Reiss K, Cheng W, Cirielli C, Kajstura J, Nitahara JA, Rizk M, Capogrossi MC, Anversa P. p53 induces myocyte apoptosis via the activation of the renin-angiotensin system. Exp Cell Res 1997; 234:57-65; PMID:9223370
   PubMed Web of Science ®Google Scholar
• Stambolsky P, Weisz L, Shats I, Klein Y, Goldfinger N, Oren M, Rotter V. Regulation of AIF expression by p53. Cell Death Differ 2006; 13:2140-49; PMID:16729031
   PubMed Web of Science ®Google Scholar
• Wu M, Xu LG, Su T, Tian Y, Zhai Z, Shu HB. AMID is a p53-inducible gene downregulated in tumors. Oncogene 2004; 23:6815-9; PMID:15273740
   PubMed Web of Science ®Google Scholar
• Lecona E, Barrasa JI, Olmo N, Llorente B, Turnay J, Lizarbe MA. Upregulation of annexin A1 expression by butyrate in human colon adenocarcinoma cells: Role of p53 NF-Y and p38 mitogen-activated protein kinase. Mol Cell Biol 2008; 28:4665-74; PMID:18541673; http://dx.doi.org/10.1128/MCB.00650-07
   PubMed Web of Science ®Google Scholar
• Robles AI, Bemmels NA, Foraker AB, Harris CC. APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis. Cancer Res 2001; 61:6660-4; PMID:11559530
   PubMed Web of Science ®Google Scholar
• Fortin A, Cregan SP, MacLaurin JG, Kushwaha N, Hickman ES, Thompson CS, Hakim A, Albert PR, Cecconi F, Helin K, et al. APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death. J Cell Biol 2001; 155:207-16; PMID:11591730
   PubMed Web of Science ®Google Scholar
• Rozenfeld-Granot G, Krishnamurthy J, Kannan K, Toren A, Amariglio N, Givol D, Rechavi G. A positive feedback mechanism in the transcriptional activation of Apaf-1 by p53 and the coactivator Zac-1. Oncogene 2002; 21:1469-76; PMID:11896574
   PubMed Web of Science ®Google Scholar
• Vrba L, Junk DJ, Novak P, Futscher BW. p53 induces distinct epigenetic states at its direct target promoters. BMC Genomics 2008; 9:486; PMID:18922183; http://dx.doi.org/10.1186/1471-2164-9-486
   PubMed Web of Science ®Google Scholar
• Wallace DM, Cotter TG. Histone Deacetylase Activity in Conjunction With E2F-1 and p53 Regulates Apaf-1 Expression in 661 W Cells and the Retina. J Neurosci Res 2009; 87 887-905; PMID:18951482; http://dx.doi.org/10.1002/jnr.21910
   PubMed Web of Science ®Google Scholar
• Jaiswal AS, Narayan S. p53-dependent transcriptional regulation of the APC promoter in colon cancer cells treated with DNA alkylating agents. J Biol Chem 2001; 276:18193-9; PMID:11279192
   PubMed Web of Science ®Google Scholar
• Ma KW, Araki K, Ichwan SJ, Suganuma T, Tamamori-Adachi M, Ikeda MA. E2FBP1DRIL1 an AT-rich interaction domain-family transcription factor is regulated by p53. Mol Cancer Res 2003; 1:438-44; PMID:12692263
   PubMed Web of Science ®Google Scholar
• Zhang C, Gao C, Kawauchi J, Hashimoto Y, Tsuchida N, Kitajima S. Transcriptional activation of the human stress-inducible transcriptional repressor ATF3 gene promoter by p53. Biochem Biophys Res Commun 2002; 297:1302-10; PMID:12372430
   PubMed Web of Science ®Google Scholar
• Graupner V, Alexander E, Overkamp T, Rothfuss O, De Laurenzi V, Gillissen BF, Daniel PT, Schulze-Osthoff K, Essmann F. Differential regulation of the proapoptotic multidomain protein Bak by p53 and p73 at the promoter level. Cell Death Differ 2011; 18:1130-9; PMID:21233848; http://dx.doi.org/10.1038/cdd.2010.179
   PubMed Web of Science ®Google Scholar
• Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994; 9:1799-805; PMID:8183579
   PubMed Web of Science ®Google Scholar
• Thornborrow EC, Patel S, Mastropietro AE, Schwartzfarb EM, Manfredi JJ. A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes. Oncogene 2002; 21:990-9; PMID:11850816
   PubMed Web of Science ®Google Scholar
• Nakano K, Vousden KH. PUMA a novel proapoptotic gene is induced by p53. Mol Cell 2001; 7:683-94; PMID:11463392
   PubMed Web of Science ®Google Scholar
• Miled C, Pontoglio M, Garbay S, Yaniv M, Weitzman JB. A genomic map of p53 binding sites identifies novel p53 targets involved in an apoptotic network. Cancer Res 2005; 65:5096-104; PMID:15958553
   PubMed Web of Science ®Google Scholar
• Margalit O, Amram H, Amariglio N, Simon AJ, Shaklai S, Granot G, Minsky N, Shimoni A, Harmelin A, Givol D, et al. BCL6 is regulated by p53 through a response element frequently disrupted in B-cell non-Hodgkin lymphoma. Blood 2006; 107:1599-607; PMID:16249378
   PubMed Web of Science ®Google Scholar
• Saifudeen Z, Du H, Dipp S, El-Dahr SS. The bradykinin type 2 receptor is a target for p53-mediated transcriptional activation. J Biol Chem 2000; 275:15557-62; PMID:10748162
   PubMed Web of Science ®Google Scholar
• Saifudeen Z, Dipp S, Fan H, El-Dahr SS. Combinatorial control of the bradykinin B2 receptor promoter by p53 CREB KLF-4 and CBP: implications for terminal nephron differentiation. Am J Physiol-Renal Physiol 2005; 288:F899-F909; PMID:15632413
   PubMedGoogle Scholar
• Sax JK, Fei P, Murphy ME, Bernhard E, Korsmeyer SJ, El-Deiry WS. BID regulation by p53 contributes to chemosensitivity. Nat Cell Biol 2002; 4:842-9; PMID:12402042
   PubMed Web of Science ®Google Scholar
• Fei PW, Wang W, Kim SH, Wang S, Burns TF, Sax JK, Buzzai M, Dicker DT, McKenna WG, Bernhard EJ, et al. Bnip3L is induced by p53 under hypoxia and its knockdown promotes tumor growth. Cancer Cell 2004; 6:597-609; PMID:15607964
   PubMed Web of Science ®Google Scholar
• Rouault JP, Falette N, Guéhenneux F, Guillot C, Rimokh R, Wang Q, Berthet C, Moyret-Lalle C, Savatier P, Pain B, et al. Identification of BTG2 an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet 1996; 14:482-6; PMID:8944033
   PubMed Web of Science ®Google Scholar
• Duriez C, Falette N, Audoynaud C, Moyret-Lalle C, Bensaad K, Courtois S, Wang Q, Soussi T, Puisieux A. The human BTG2TIS21PC3 gene: genomic structure transcriptional regulation and evaluation as a candidate tumor suppressor gene. Gene 2002; 282:207-14; PMID:11814693
   PubMed Web of Science ®Google Scholar
• Ou YH, Chung PH, Hsu FF, Sun TP, Chang WY, Shieh SY. The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1. EMBO J 2007; 26:3968-80; PMID:17690688
   PubMed Web of Science ®Google Scholar
• Jen KY, Cheung VG. Identification of novel p53 target genes in ionizing radiation response. Cancer Res 2005; 65:7666-73; PMID:16140933
   PubMed Web of Science ®Google Scholar
• Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E, Vousden KH. TIGAR a p53-inducible regulator of glycolysis and apoptosis. Cell 2006; 126:107-20; PMID:16839880
   PubMed Web of Science ®Google Scholar
• Saigusa K, Imoto I, Tanikawa C, Aoyagi M, Ohno K, Nakamura Y, Inazawa J. RGC32 a novel p53-inducible gene is located on centrosomes during mitosis and results in G2M arrest. Oncogene 2007; 26:1110-21; PMID:17146433
   PubMed Web of Science ®Google Scholar
• Brown L, Ongusaha PP, Kim HG, Nuti S, Mandinova A, Lee JW, Khosravi-Far R, Aaronson SA, Lee SW. CDIP a novel pro-apoptotic gene regulates TNF alpha-mediated apoptosis in a p53-dependent manner. EMBO J 2007; 26:3410-22; PMID:17599062
   PubMed Web of Science ®Google Scholar
• Gupta S, Radha V, Furukawa Y, Swarup G. Direct transcriptional activation of human caspase-1 by tumor suppressor p53. J Biol Chem 2001; 276:10585-8; PMID:11278253
   PubMed Web of Science ®Google Scholar
• Rikhof B, Corn PG, el-Deiry WS. Caspase 10 levels are increased following DNA damage in a p53-dependent manner. Cancer Biol Ther 2003; 2:707-12; PMID:14688482
   PubMed Web of Science ®Google Scholar
• MacLachan TK, el-Deiry WS. Apoptotic threshold is lowered by p53 transactivation of caspase-6. Proc Natl Acad Sci USA 2002; 99:9492-7; PMID:12089322
   PubMed Web of Science ®Google Scholar
• Bist A, Fielding CJ, Fielding PE. p53 regulates caveolin gene transcription cell cholesterol and growth by a novel mechanism. Biochem 2000; 39:1966-72; PMID:10684646
   PubMed Web of Science ®Google Scholar
• Yu X, Riley T, Levine AJ. The regulation of the endosomal compartment by p53 the tumor suppressor gene. FEBS J 2009; 276:2201-12; PMID:19302216; http://dx.doi.org/10.1111/j.1742-4658.2009.06949.x
   PubMed Web of Science ®Google Scholar
• Okamoto K, Beach D. Cyclin-G Is A transcriptional target of the P53 tumor-suppressor protein. EMBO J 1994; 13:4816-22; PMID:7957050
   PubMed Web of Science ®Google Scholar
• Zauberman A, Lupo A, Oren M. Identification of P53 target genes through immune selection of genomic DNA - the cyclin-G gene contains 2 distinct P53 binding-sites. Oncogene 1995; 10:2361-6; PMID:7784084
   PubMed Web of Science ®Google Scholar
• Mori T, Anazawa Y, Matsui K, Fukuda S, Nakamura Y, Arakawa H. Cyclin K as a direct transcriptional target of the p53 tumor suppressor. Neoplasia 2002; 4:268-74; PMID:11988847
   PubMed Web of Science ®Google Scholar
• Mashimo T, Watabe M, Hirota S, Hosobe S, Miura K, Tegtmeyer PJ, Rinker-Shaeffer CW, Watabe K. The expression of the KAI1 gene a tumor metastasis suppressor is directly activated by p53. Proc Natl Acad Sci USA 1998; 95:11307-11; PMID:9736732
   PubMed Web of Science ®Google Scholar
• Resnick-Silverman L, St Clair S, Maurer M, Zhao K, Manfredi JJ. Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53. Gen Dev 1998; 12:2102-7; PMID:9679054
   PubMed Web of Science ®Google Scholar
• el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B. Definition of a consensus binding site for p53. Nat. Genet 1992; 1:45-9; PMID:1301998
   PubMed Web of Science ®Google Scholar
• el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1 a potential mediator of p53 tumor suppression. Cell 1993; 75:817-25; PMID:8242752
   PubMed Web of Science ®Google Scholar
• Hearnes JM, Mays DJ, Schavolt KL, Tang L, Jiang X, Pietenpol JA. Chromatin immunoprecipitation-based screen to identify functional genomic binding sites for sequence-specific transactivators. Mol Cell Biol 2005; 25:10148-58; PMID:16260627
   PubMed Web of Science ®Google Scholar
• Saramaki A, Banwell CM, Campbell MJ, Carlberg C. Regulation of the human p21((waf1cip1)) gene promoter via multiple binding sites for p53 and the vitamin D-3 receptor. Nucleic Acids Res 2006; 34:543-54; PMID:16434701
   PubMed Web of Science ®Google Scholar
• Sohr S, Engeland K. The tumor suppressor p53 induces expression of the pregnancy-supporting human chorionic gonadotropin (hCG) CGB7 gene. Cell Cycle 2011; 10:3758-67; PMID:22032922; http://dx.doi.org/10.4161/cc.10.21.17946
   PubMed Web of Science ®Google Scholar
• Jackson P, Shield M, Buskin J, Hawkes S, Reed M, Perrem K, Hauschka SD, Braithwaite A. P53-dependent activation of the mouse Mck gene promoter - identification of a novel P53-responsive sequence and evidence for cooperation between distinct P53 binding-sites. Gene Expr 1995; 5:19-33; PMID:7488858
   PubMed Web of Science ®Google Scholar
• Zhao JQ, Schmieg FI, Logsdon N, Freedman D, Simmons DT, Molloy GR. p53 binds to a novel recognition sequence in the proximal promoter of the rat muscle creatine kinase gene and activates its transcription. Oncogene 1996; 13:293-302; PMID:8710368
   PubMed Web of Science ®Google Scholar
• Wang LQ, Wu Q, Qiu P, Mirza A, McGuirk M, Kirschmeier P, Greene JR, Wang Y, Pickett CB, Liu S. Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches. J Biol Chem 2001; 276:43604-10; PMID:11571296
   PubMed Web of Science ®Google Scholar
• Wu GS, Saftig P, Peters C, el-Deiry WS. Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity. Oncogene 1998; 16:2177-83; PMID:9619826
   PubMed Web of Science ®Google Scholar
• Shiraishi K, Fukuda S, Mori T, Matsuda K, Yamaguchi T, Tanikawa C, Ogawa M, Nakamura Y, Arakawa H. Identification of fractalkine a CX3C-type chemokine as a direct target of p53. Cancer Res 2000; 60:3722-26; PMID:10919640
   PubMed Web of Science ®Google Scholar
• Jackson RS, Cho YJ, Stein S, Liang P. CYFIP2 a direct p53 target is leptomycin-B sensitive. Cell Cycle 2007; 6:95-103; PMID:17245118
   PubMed Web of Science ®Google Scholar
• Kudoh T, Kimura J, Lu ZG, Miki Y, Yoshida K. D4S234E a novel p53-responsive gene induces apoptosis in response to DNA damage. Exp Cell Res 2010; 316:2849-58; PMID:20599942; http://dx.doi.org/10.1016/j.yexcr.2010.06.025
   PubMed Web of Science ®Google Scholar
• Ohnishi S, Futamura M, Kamino H, Nakamura Y, Kitamura N, Miyamoto Y, Miyamoto T, Shinogi D, Goda O, Arakawa H. Identification of NEEP21 encoding neuron-enriched endosomal protein of 21 kDa as a transcriptional target of tumor suppressor p53. Int J Oncol 2010; 37:1133-41; PMID:20878061
   PubMed Web of Science ®Google Scholar
• Martoriati A, Doumont G, Alcalay M, Bellefroid E, Pelicci PG, Marine JC. dapk1 encoding an activator of a p19(ARF)-p53-mediated apoptotic checkpoint is a transcription target of p53. Oncogene 2005; 24:1461-6; PMID:15608685
   PubMed Web of Science ®Google Scholar
• Tan T, Chu G. p53 binds and activates the xeroderma pigmentosum DDB2 gene in humans but not mice. Mol Cell Biol 2002; 22:3247-54; PMID:11971958
   PubMed Web of Science ®Google Scholar
• Sakuma S, Saya H, Tada M, Nakao M, Fujiwara T, Roth JA, Sawamura Y, Shinohe Y, Abe H. Receptor protein tyrosine kinase DDR is up-regulated by p53 protein. FEBS Lett 1996; 398:165-9; PMID:8977099
   PubMed Web of Science ®Google Scholar
• Qian YJ, Zhang J, Yan BF, Chen XB. DEC1 a basic helix-loop-helix transcription factor and a novel target gene of the p53 family mediates p53-dependent premature senescence. J Biol Chem 2008; 283:2896-905; PMID:18025081
   PubMed Web of Science ®Google Scholar
• Kirschner RD, Rother K, Müller GA, Engeland K. The retinal dehydrogenasereductase retSDR1DHRS3 gene is activated by p53 and p63 but not by mutants derived from tumors or EECADULT malformation syndromes. Cell Cycle 2010; 9:2177-88; PMID:20543567
   PubMed Web of Science ®Google Scholar
• Wang J, Shou J, Chen X. Dickkopf-1 an inhibitor of the Wnt signaling pathway is induced by p53. Oncogene 2000; 19:1843-8; PMID:10777218
   PubMed Web of Science ®Google Scholar
• Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P, Harrison PR, Gasco M, Garrone O, Crook T, Ryan KM. DRAM a p53-induced modulator of autophagy is critical for apoptosis. Cell 2006; 126:121-34; PMID:16839881
   PubMed Web of Science ®Google Scholar
• Li MX, Zhou JY, Ge YB, Matherly LH, Wu GS. The phosphatase MKP1 is a transcriptional target of p53 involved in cell cycle regulation. J Biol Chem 2003; 278:41059-68; PMID:12890671
   PubMed Web of Science ®Google Scholar
• Yang HJ, Wu GS. p53 transactivates the phosphatase MKP1 through both intronic and exonic p53 responsive elements. Cancer Biol Ther 2004; 3:1277-82; PMID:15611668
   PubMed Web of Science ®Google Scholar
• Liu YX, Wang J, Guo J, Wu J, Lieberman HB, Yin Y. DUSP1 is controlled by p53 during the cellular response to oxidative stress. Mole Cancer Res 2008; 6:624-33; PMID:18403641; http://dx.doi.org/10.1158/1541-7786.MCR-07-2019
   PubMed Web of Science ®Google Scholar
• Yin Y, Liu YX, Jin YJ, Hall EJ, Barrett JC. PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression. Nature 2003; 422:527-31; PMID:12673251
   PubMed Web of Science ®Google Scholar
• Shen WH, Wang JL, Wu JJ, Zhurkin VB, Yin YX. Mitogen-activated protein kinase phosphatase 2: A novel transcription target of p53 in apoptosis. Cancer Res 2006; 66:6033-9; PMID:16778175
   PubMed Web of Science ®Google Scholar
• Ueda K, Arakawa H, Nakamura Y. Dual-specificity phosphatase 5 (DUSP5) as a direct transcriptional target of tumor suppressor p53. Oncogene 2003; 22:5586-91; PMID:12944906
   PubMed Web of Science ®Google Scholar
• Piya S, Kim JY, Bae J, Seol DW, Moon AR, Kim TH. DUSP6 is a novel transcriptional target of p53 and regulates p53-mediated apoptosis by modulating expression levels of Bcl-2 family proteins. FEBS Lett. 2012; 586:4233-40; PMID:23108049; http://dx.doi.org/10.1016/j.febslet.2012.10.031
   PubMed Web of Science ®Google Scholar
• Carvajal LA, Hamard PJ, Tonnessen C, Manfredi JJ. E2F7 a novel target is up-regulated by p53 and mediates DNA damage-dependent transcriptional repression. Genes Dev 2012; 26:1533-45; PMID:22802528; http://dx.doi.org/10.1101/gad.184911.111
   PubMed Web of Science ®Google Scholar
• Tanikawa C, Furukawa Y, Yoshida N, Arakawa H, Nakamura Y, Matsuda K. XEDAR as a putative colorectal tumor suppressor that mediates p53-regulated anoikis pathway. Oncogene 2009; 28:3081-92; PMID:19543321; http://dx.doi.org/10.1038/onc.2009.154
   PubMed Web of Science ®Google Scholar
• LudesMeyers JH, Subler MA, Shivakumar CV, Munoz RM, Jiang P, Bigger JE, Brown DR, Deb SP, Deb S. Transcriptional activation of the human epidermal growth factor receptor promoter by human p53. Mol Cell Biol 1996; 16:6009-19; PMID:8887630
   PubMed Web of Science ®Google Scholar
• Jin YJ, Wang J, Qiao C, Hei TK, Brandt-Rauf PW, Yin Y. A novel mechanism for p53 to regulate its target gene ECK in signaling apoptosis. Mole Cancer Res 2006; 4:769-8; PMID:17050670
   PubMed Web of Science ®Google Scholar
• Wang B, Niu D, Lai L, Ren EC. p53 increases MHC class I expression by upregulating the endoplasmic reticulum aminopeptidase ERAP1. Nat Commun 2013; 4:2359; PMID:23965983; http://dx.doi.org/10.1038/ncomms3359
   PubMed Web of Science ®Google Scholar
• Shirley SH, Rundhaug JE, Tian J, Cullinan-Ammann N, Lambertz I, Conti CJ, Fuchs-Young R. Transcriptional Regulation of Estrogen Receptor-alpha by p53 in Human Breast Cancer Cells. Cancer Res 2009; 69:3405-14; PMID:19351845; http://dx.doi.org/10.1158/0008-5472.CAN-08-3628
   PubMed Web of Science ®Google Scholar
• Liebetrau W, Budde A, Savoia A, Grummt F, Hoehn H. p53 activates Fanconi anemia group C gene expression. Hu Mole Genet 1997; 6:277-83; PMID:9063748
   PubMed Web of Science ®Google Scholar
• Muller M, Wilder S, Bannasch D, Israeli D, Lehlbach K, Li-Weber M, Friedman SL, Galle PR, Stremmel W, Oren M, et al. p53 activates the CD95 (APO-1Fas) gene in response to DNA damage by anticancer drugs. J Exp Med 1998; 188:2033-45; PMID:9841917
   PubMed Web of Science ®Google Scholar
• Munsch D, Watanabe-Fukunaga R, Bourdon JC, Nagata S, May E, Yonish-Rouach E, Reisdorf P. Human and mouse Fas (APO-1CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis. J Biol Chem 2000; 275:3867-72; PMID:10660538
   PubMed Web of Science ®Google Scholar
• Schilling T, Schleithoff ES, Kairat A, Melino G, Stremmel W, Oren M, Krammer PH, Müller M. Active transcription of the human FASCD95TNFRSF6 gene involves the p53 family. Biochem Biophys Res Commun 2009; 387:399-404; PMID:19615968; http://dx.doi.org/10.1016/j.bbrc.2009.07.063
   PubMed Web of Science ®Google Scholar
• Liu G, Chen XB. The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis. Oncogene 2002; 21:7195-204; PMID:12370809
   PubMed Web of Science ®Google Scholar
• Ciribilli Y, Andreotti V, Menendez D, Langen JS, Schoenfelder G, Resnick MA, Inga A. The coordinated P53 and estrogen receptor cis-regulation at an FLT1 promoter SNP is specific to genotoxic stress and estrogenic compound. PLoS One 2010; 5(4):e10236; PMID:20422012; http://dx.doi.org/10.1371/journal.pone.0010236
   PubMedGoogle Scholar
• Elkeles A, Juven-Gershon T, Israeli D, Wilder S, Zalcenstein A, Oren M. The c-fos proto-oncogene is a target for transactivation by the p53 tumor suppressor. Mol Cell Biol 1999; 19:2594-600; PMID:10082525
   PubMed Web of Science ®Google Scholar
• Singh S, Raina V, Chavali PL, Dubash T, Kadreppa S, Parab P, Chattopadhyay S. Regulation of GAD65 expression by SMAR1 and p53 upon Streptozotocin treatment. Bmc Molecular Biology 2012; 13:28; PMID:22978699
   PubMed Web of Science ®Google Scholar
• Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 1992; 71:587-97; PMID:1423616
   PubMed Web of Science ®Google Scholar
• Ide T, Brown-Endres L, Chu K, Ongusaha PP, Ohtsuka T, El-Deiry WS, Aaronson SA, Lee SW. GAMT a p53-inducible modulator of apoptosis is critical for the adaptive response to nutrient stress (Retracted article. See vol. 51 pg. 552 2013). Mole Cell 2009; 36:379-92; PMID:19917247; http://dx.doi.org/10.1016/j.molcel.2009.09.031
   PubMed Web of Science ®Google Scholar
• Zhu ZX, Wei J, Shi Z, Yang Y, Shao D, Li B, Wang X, Ma Z. Identification of human guanylate-binding protein 1 gene (hGBP1) as a direct transcriptional target gene of p53. Biochem Biophys Res Commun 2013; 436:204-11; PMID:23727578; http://dx.doi.org/10.1016/j.bbrc.2013.05.074
   PubMed Web of Science ®Google Scholar
• Tan MJ, Wang YX, Guan KL, Sun Y. PTCF-beta a type beta transforming growth factor (TGF-beta) superfamily member is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway. Proc Natl Acad Sci USA 2000; 97:109-4; PMID:10618379
   PubMed Web of Science ®Google Scholar
• Osada M, Park HL, Park MJ, Liu JW, Wu G, Trink B, Sidransky D. A p53-type response element in the GDF15 promoter confers high specificity for p53 activation. Biochem Biophys Res Commun 2007; 354:913-8; PMID:17276395
   PubMed Web of Science ®Google Scholar
• Suzuki S, Tanaka T, Poyurovsky MV, Nagano H, Mayama T, Ohkubo S, Lokshin M, Hosokawa H, Nakayama T, Suzuki Y, et al. Phosphate-activated glutaminase (GLS2) a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc Natl Acad Sci USA 2010; 107 7461-6; PMID:20351271; http://dx.doi.org/10.1073/pnas.1002459107
   PubMedGoogle Scholar
• Zhang YH, Qian YJ, Lu WF, Chen XB. The G protein-coupled receptor 87 is necessary for p53-dependent cell survival in response to genotoxic stress. Cancer Res 2009; 69:6049-56; PMID:19602589; http://dx.doi.org/10.1158/0008-5472.CAN-09-0621
   PubMed Web of Science ®Google Scholar
• Tan MJ, Li S, Swaroop M, Guan K, Oberley LW, Sun Y. Transcriptional activation of the human glutathione peroxidase promoter by p53. J Biol Chem 1999; 274:12061-6; PMID:10207030
   PubMed Web of Science ®Google Scholar
• Lo HW, Stephenson L, Cao X, Milas M, Pollock R, Ali-Osman F. Identification and functional characterization of the human glutathione S-transferase P1 gene as a novel transcriptional target of the p53 tumor suppressor gene. Mole Cancer Res 2008; 6 843-50; PMID:18505928; http://dx.doi.org/10.1158/1541-7786.MCR-07-2105
   PubMed Web of Science ®Google Scholar
• Weizer-Stern O, Adamsky K, Margalit O, Ashur-Fabian O, Givol D, Amariglio N, Rechavi G. Hepcidin a key regulator of iron metabolism is transcriptionally activated by p53. Br J Haematol 2007; 138:253-62; PMID:17593032
   PubMed Web of Science ®Google Scholar
• Wu XW, Bayle JH, Olson D, Levine AJ. The P53 Mdm-2 autoregulatory feedback loop. Genes Dev 1993; 7:1126-32; PMID:8319905
   PubMed Web of Science ®Google Scholar
• Juven T, Barak Y, Zauberman A, George DL, Oren M. Wild-type P53 can mediate sequence-specific transactivation of an internal promoter within the Mdm2 gene. Oncogene 1993; 8:3411-6.
   PubMed Web of Science ®Google Scholar
• Barak Y, Juven T, Haffner R, Oren M. mdm2 expression is induced by wild type p53 activity. EMBO J 1993; 12 461-8; PMID:8440237
   PubMed Web of Science ®Google Scholar
• Zauberman A, Flusberg D, Haupt Y, Barak Y, Oren M. A functional P53-responsive intronic promoter is contained within the human Mdm2 gene. Nucleic Acids Res 1995; 23:2584-92; PMID:7651818
   PubMed Web of Science ®Google Scholar
• Saucedo LJ, Carstens BP, Seavey SE, Albee LD, Perry ME. Regulation of transcriptional activation of mdm2 gene by p53 in response to UV radiation. Cell Growth Differ 1998; 9:119-30; PMID:9486848
   PubMedGoogle Scholar
• Britschgi C, Rizzi M, Grob TJ, Tschan MP, Hügli B, Reddy VA, Andres AC, Torbett BE, Tobler A, Fey MF. Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1. Oncogene 2006;l 25:2030-9; PMID:16301995
   PubMed Web of Science ®Google Scholar
• Baraz L, Haupt Y, Elkin M, Peretz T, Vlodavsky I. Tumor suppressor p53 regulates heparanase gene expression. Oncogene 2006; 25 3939-47; PMID:16474844
   PubMed Web of Science ®Google Scholar
• Deguin-Chambon V, Vacher M, Jullien M, May E, Bourdon JC, Direct transactivation of c-Ha-Ras gene by p53: evidence for its involvement in p53 transactivation activity and p53-mediated apoptosis. Oncogene 2000; 19:5831-41; PMID:11127813
   PubMed Web of Science ®Google Scholar
• Feng Z, Jin S, Zupnick A, Hoh J, de Stanchina E, Lowe S, Prives C, Levine AJ. p53 tumor suppressor protein regulates the levels of huntingtin gene expression. Oncogene 2006; 25:1-7; PMID:16278683
   PubMed Web of Science ®Google Scholar
• Schafer H, Trauzold A, Sebens T, Deppert W, Fölsch UR, Schmidt WE. The proliferation-associated early response gene p22PRG1 is a novel p53 target gene. Oncogene 1998; 16:2479-87; PMID:9627114
   PubMed Web of Science ®Google Scholar
• Schafer H, Diebel J, Arlt A, Trauzold A, Schmidt WE. The promoter of human p22PACAP response gene 1 (PRG1) contains functional binding sites for the p53 tumor suppressor and for NF kappa B. FEBS Lett 1998; 436 139-43; PMID:9781666
   PubMed Web of Science ®Google Scholar
• Huang YH, Wu JYJ, Zhang YJ, Wu MX. Synergistic and opposing regulation of the stress-responsive gene IEX-1 by p53 c-Myc and multiple NF-kappa Brel complexes. Oncogene 2002; 21:6819-28; PMID:12360408
   PubMed Web of Science ®Google Scholar
• Song LL, Alimirah F, Panchanathan R, Xin H, Choubeyt D. Expression of an IFN-inducible cellular senescence gene IFI16 Is up-regulated by p53. Mole Cancer Res 2008; 6:1732-41; PMID:18974396; http://dx.doi.org/10.1158/1541-7786.MCR-08-0208
   PubMed Web of Science ®Google Scholar
• Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR, Kley N. Induction of the growth inhibitor Igf-binding protein-3 by P53. Nature 1995; 377:646-9; PMID:7566179
   PubMed Web of Science ®Google Scholar
• Koeppel M, van Heeringen SJ, Smeenk L, Navis AC, Janssen-Megens EM, Lohrum M. The novel p53 target gene IRF2BP2 participates in cell survival during the p53 stress response. Nucleic Acids Res 2009; 37:322-5; PMID:19042971; http://dx.doi.org/10.1093/nar/gkn940
   PubMed Web of Science ®Google Scholar
• Mori T, Anazawa Y, Iiizumi M, Fukuda S, Nakamura Y, Arakawa H. Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53. Oncogene 2002; 21 2914-8; PMID:11973653
   PubMed Web of Science ®Google Scholar
• Cui HY, Kamino H, Nakamura Y, Kitamura N, Miyamoto T, Shinogi D, Goda O, Arakara H, Futamura M. Regulation of apoptosis by p53-inducible transmembrane protein containing sushi domain. Oncol Rep 2010; 24:1193-200; PMID:20878110
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay T, Roth JA. p53 involvement in activation of the cytokeratin 8 gene in tumor cell lines. Anticancer Res 1996; 16:105-12; PMID:8615594
   PubMed Web of Science ®Google Scholar
• Hu W, Feng Z, Teresky AK, Levine AJ. p53 regulates maternal reproduction through LIF. Nature 2007; 450:721-4; PMID:18046411
   PubMed Web of Science ®Google Scholar
• Assaily W, Rubinger DA, Wheaton K, Lin Y, Ma W, Xuan W, Brown-Endres L, Tsuchihara K, Mak TW, Benchimol S. ROS-mediated p53 induction of Lpin1 regulates fatty acid oxidation in response to nutritional stress. Mol. Cell 2011; 44:491-501; PMID:22055193; http://dx.doi.org/10.1016/j.molcel.2011.08.038
   PubMed Web of Science ®Google Scholar
• Seol DW, Chen QY, Smith ML, Zarnegar R. Regulation of the c-met proto-oncogene promoter by p53. J Biol Chem 1999; 274:3565-72; PMID:9920903
   PubMed Web of Science ®Google Scholar
• Wang WL, Cheng X, Lu J, Wei J, Fu G, Zhu F, Jia C, Zhou L, Xie H, Zheng S. Mitofusin-2 is a novel direct target of p53. Biochem Biophys Res Commun 2010; 400:587-92; PMID:20804729; http://dx.doi.org/10.1016/j.bbrc.2010.08.108
   PubMed Web of Science ®Google Scholar
• Chen JG, Sadowski I. Identification of the mismatch repair genes PMS2 and MLH1 as p53 target genes by using serial analysis of binding elements. Proc Natl Acad Sci USA 2005; 102:4813-8; PMID:15781865
   PubMed Web of Science ®Google Scholar
• Bian JH, Sun Y, Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol Cell Biol 1997; 17:6330-8; PMID:9343394
   PubMed Web of Science ®Google Scholar
• Staun-Ram E, Goldman S, Shalev E. Ets-2 and p53 mediate cAMP-induced MMP-2 expression activity and trophoblast invasion. Reprod Biol Endocrinol 2009; 7:135; PMID:19939245; http://dx.doi.org/10.1186/1477-7827-7-135
   PubMed Web of Science ®Google Scholar
• Stein S, Thomas EK, Herzog B, Westfall MD, Rocheleau JV, Jackson RS 2nd, Wang M, Liang P. NDRG1 is necessary for p53-dependent apoptosis. J Biol Chem 2004; 279:48930-40; PMID:15377670
   PubMed Web of Science ®Google Scholar
• Cho SJ, Rossi A, Jung YS, Yan W, Liu G, Zhang J, Zhang M, Chen X. Ninjurin1 a target of p53 regulates p53 expression and p53-dependent cell survival senescence and radiation-induced mortality. Proc Natl Acad Sci USA 2013; 110:9362-7; PMID:23690620; http://dx.doi.org/10.1073/pnas.1221242110
   PubMed Web of Science ®Google Scholar
• Sadasivam S, Gupta S, Radha V, Batta K, Kundu TK, Swarup G. Caspase-1 activator Ipaf is a p53-inducible gene involved in apoptosis. Oncogene 2005; 24 627-36; PMID:15580302
   PubMed Web of Science ®Google Scholar
• Lefort K, Mandinova A, Ostano P, Kolev V, Calpini V, Kolfschoten I, Devgan V, Lieb J, Raffoul W, Hohl D, et al. Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK12 and MRCK alpha kinases. Genes Dev 2007; 21:562-77; PMID:17344417
   PubMed Web of Science ®Google Scholar
• Yugawa T, Handa K, Narisawa-Saito M, Ohno S, Fujita M, Kiyono T. Regulation of Notch1 gene expression by p53 in epithelial cells. Mol Cell Biol 2007; 27:3732-42; PMID:17353266
   PubMed Web of Science ®Google Scholar
• Böhlig L, Metzger R, Rother K, Till H, Engeland K. The CCN3 gene coding for an extracellular adhesion-related protein is transcriptionally activated by the p53 tumor suppressor. Cell Cycle 2008; 7:1254-61; PMID:18418052
   PubMed Web of Science ®Google Scholar
• Tasheva ES, Maki CG, Conrad AH, Conrad GW. Transcriptional activation of bovine mimecan by p53 through an intronic DNA-binding site. Biochim Biophys Acta 2001; 1517:333-8; PMID:11342211
   PubMed Web of Science ®Google Scholar
• Saifudeen Z, Liu J, Dipp S, Yao X, Li Y, McLaughlin N, Aboudehen K, El-Dahr SS. A p53-pax2 pathway in kidney development: implications for nephrogenesis. PLoS One 2012; 7(9):e44869; PMID:22984579; http://dx.doi.org/10.1371/journal.pone.0044869
   PubMed Web of Science ®Google Scholar
• Zhu JH, Chen XB. MCG10 a novel p53 target gene that encodes a KH domain RNA-binding protein is capable of inducing apoptosis and cell cycle arrest in G(2)-M. Mol Cell Biol 2000; 20:5602-18; PMID:10891498
   PubMed Web of Science ®Google Scholar
• Shivakumar CV, Brown DR, Deb S, Deb SP. Wild-type human P53 transactivates the human proliferating cell nuclear antigen promoter. Mol Cell Biol 1995; 15:6785-93; PMID:8524244
   PubMed Web of Science ®Google Scholar
• Morris GF, Bischoff JR, Mathews MB. Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53. Proc Natl Acad Sci USA 1996; 93:895-9; PMID:8570655
   PubMedGoogle Scholar
• Shan B, Xu J, Zhuo Y, Morris CA, Morris GF. Induction of p53-dependent activation of the human proliferating cell nuclear antigen gene in chromatin by ionizing radiation. J Biol Chem 2003; 278:44009-17; PMID:12947108
   PubMed Web of Science ®Google Scholar
• Shan B, Morris GF. Binding sequence-dopendent regulation of the human proliferating cell nuclear antigen promoter by p53. Exp Cell Res 2005; 305:10-22; PMID:15777783
   PubMed Web of Science ®Google Scholar
• Lee SJ, Lee SH, Yoon MH, Park BJ. A new p53 target gene RKIP is essential for DNA damage-induced cellular senescence and suppression of ERK activation. Neoplasia 2013; 15:727-37; PMID:23814485
   PubMed Web of Science ®Google Scholar
• Reczek EE, Flores ER, Tsay AS, Attardi LD, Jacks T. Multiple response elements and differential p53 binding control perp expression during apoptosis. Mole Cancer Res 2003; 1:1048-57; PMID:14707288
   PubMed Web of Science ®Google Scholar
• Lin YP, Ma WL, Benchimol S. Pidd a new death-domain-containing protein is induced by p53 and promotes apoptosis. Nat Genet 2000; 26:122-5; PMID:10973264
   PubMed Web of Science ®Google Scholar
• Burns TF, Fei PW, Scata KA, Dicker DT, el-Deiry WS. Silencing of the novel p53 target gene SnkPlk2 leads to mitotic catastrophe in paclitaxel (Taxol)-exposed cells. Mol Cell Biol 2003; 23:5556-71; PMID:12897130
   PubMed Web of Science ®Google Scholar
• Hudson CD, Morris PJ, Latchman DS, Budhram-Mahadeo VS. Brn-3a transcription factor blocks p53-mediated activation of proapoptotic target genes Noxa and Bax in vitro and in vivo to determine cell fate. J Biol Chem 2005; 280:11851-8; PMID:15598651
   PubMed Web of Science ®Google Scholar
• de Stanchina E, Querido E, Narita M, Davuluri RV, Pandolfi PP, Ferbeyre G, Lowe SW. PML is a direct p53 target that modulates p53 effector functions. Mole Cell 2004; 13:523-35; PMID:14992722
   PubMed Web of Science ®Google Scholar
• Rossi M, Demidov.ON, Anderson CW, Appella E, Mazur SJ. Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites. Nucleic Acids Res 2008; 36:7168-80; PMID:19015127; http://dx.doi.org/10.1093/nar/gkn888
   PubMed Web of Science ®Google Scholar
• Yan JL, Jiang J, Lim CA, Wu Q, Ng HH, Chin KC. BLIMP1 regulates cell growth through repression of p53 transcription. Proc Natl Acad Sci USA 2007; 104:1841-6; PMID:17264218
   PubMedGoogle Scholar
• Stambolic V, MacPherson D, Sas D, Lin Y, Snow B, Jang Y, Benchimol S, Mak TW. Regulation of PTEN transcription by p53. Mole Cell 2001; 8:317-25; PMID:11545734
   PubMed Web of Science ®Google Scholar
• Min SH, Kim DM, Heo YS, Kim YI, Kim HM, Kim J, Han YM>, Kim IC, Yoo OJ. New p53 target phosphatase of regenerating liver 1 (PRL-1) downregulates p53. Oncogene 2009; 28 545-54; PMID:18997816; http://dx.doi.org/10.1038/onc.2008.409
   PubMed Web of Science ®Google Scholar
• Doumont G, Martoriati A, Marine JC. PTPRV is a key mediator of p53-induced cell cycle exit. Cell Cycle 2005; 4:1703-5; PMID:16258284
   PubMed Web of Science ®Google Scholar
• Huang BH, Zhuo JL, Leung CH, Lu GD, Liu JJ, Yap CT, Hooi SC. PRAP1 is a novel executor of p53-dependent mechanisms in cell survival after DNA damage. Cell Death Disease 2012; 3:e442; PMID:23235459; http://dx.doi.org/10.1038/cddis.2012.180
   PubMedGoogle Scholar
• Feng ZH, Hu W, de Stanchina E, Teresky AK, Jin S, Lowe S, Levine AJ. The regulation of AMPK beta 1 TSC2 and PTEN expression by p53: Stress cell and tissue specificity and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res 2007; 67:3043-53; PMID:17409411
   PubMed Web of Science ®Google Scholar
• Maxwell SA, Kochevar GJ. Identification of a p53-response element in the promoter of the proline oxidase gene. Biochem Biophys Res Commun 2008; 369:308-13; PMID:18279664; http://dx.doi.org/10.1016/j.bbrc.2008.01.171
   PubMed Web of Science ®Google Scholar
• Raimondi I, Ciribilli Y, Monti P, Bisio A, Pollegioni L, Fronza G, Inga A, Campomenosi P. P53 Family members modulate the expression of PRODH but not PRODH2 via intronic p53 response elements. PLoS One 2013; 8(7):e69152; PMID:23861960; http://dx.doi.org/10.1371/journal.pone.0069152
   PubMedGoogle Scholar
• Ohtsuka T, Ryu H, Minamishima YA, Macip S, Sagara J, Nakayama KI, Aaronson SA, Lee SW. ASC is a Bax adaptor and regulates the p53-Bax mitochondrial apoptosis pathway. Nat Cell Biol 2004; 6(2):121-8; PMID:14730312
   PubMed Web of Science ®Google Scholar
• Zhang XY, He Y, Lee KH, Dubois W, Li Z, Wu X, Kovalchuk A, Zhang W, Huang J. Rap2b a novel p53 target regulates p53-mediated pro-survival function. Cell Cycle 2013; 12:1279-91; PMID:23535297; http://dx.doi.org/10.4161/cc.24364
   PubMed Web of Science ®Google Scholar
• Tian K, Wang Y, Xu H. WTH3 is a direct target of the p53 protein. Br J Cancer 2007; 96:1579-86; PMID:17426708
   PubMed Web of Science ®Google Scholar
• Hsu TH, Chu CC, Jiang SY, Hung MW, Ni WC, Lin HE, Chang TC. Expression of the class II tumor suppressor gene RIG1 is directly regulated by p53 tumor suppressor in cancer cell lines. FEBS Lett 2012; 586 1287-93; PMID:22616991; http://dx.doi.org/10.1016/j.febslet.2012.03.020
   PubMed Web of Science ®Google Scholar
• Shu LM, Yan WS, Chen XB. RNPC1 an RNA-binding protein and a target of the p53 family is required for maintaining the stability of the basal and stress-induced p21 transcript. Genes Dev 2006; 20:2961-72; PMID:17050675
   PubMed Web of Science ®Google Scholar
• Ongusaha PP, Kim JI, Fang L, Wong TW, Yancopoulos GD, Aaronson SA, Lee SW. p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop. EMBO J 2003; 22:1289-301; PMID:12628922
   PubMed Web of Science ®Google Scholar
• Ng CC, Arakawa H, Fukuda S, Kondoh H, Nakamura Y. p53RFP a p53-inducible RING-finger protein regulates the stability of p21(WAF1). Oncogene 2003; 22 4449-58; PMID:12853982
   PubMed Web of Science ®Google Scholar
• Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K, Takei Y, Nakamura Y. A ribonucleotide reductase gene involved in a p53-dependent cell- cycle checkpoint for DNA damage. Nature 2000; 404:42-9; PMID:10716435
   PubMed Web of Science ®Google Scholar
• Tan MJ, Heizmann CW, Guan KL, Schafer BW, Sun Y. Transcriptional activation of the human S100A2 promoter by wild-type p53. FEBS Lett 1999; 445:265-8; PMID:10094469
   PubMed Web of Science ®Google Scholar
• Li CS, Chen H, Ding F, Zhang Y, Luo A, Wang M, Liu Z. A novel p53 target gene S100A9 induces p53-dependent cellular apoptosis and mediates the p53 apoptosis pathway. Biochem J 2009; 422:363-72; PMID:19534726; http://dx.doi.org/10.1042/BJ20090465
   PubMed Web of Science ®Google Scholar
• Adachi K, Toyota M, Sasaki Y, Yamashita T, Ishida S, Ohe-Toyota M, Maruyama R, Hinoda Y, Saito T, Imai K, et al. Identification of SCN3B as a novel p53-inducible proapoptotic gene. Oncogene 2004; 23:7791-8; PMID:15334053
   PubMed Web of Science ®Google Scholar
• Futamura M, Kamino H, Miyamoto Y, Kitamura N, Nakamura Y, Ohnishi S, Masuda Y, Arakawa H. Possible role of semaphorin 3F a candidate tumor suppressor gene at 3p2l1.3 in p53-regulated tumor angiogenesis suppression. Cancer Res 2007; 67 1451-60; PMID:17308083
   PubMed Web of Science ®Google Scholar
• Zou Z, Gao C, Nagaich AK, Connell T, Saito S, Moul JW, Seth P, Appella E, Srivastava S. p53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem 2000; 275:6051-4; PMID:10692390
   PubMed Web of Science ®Google Scholar
• Wang SZE, Narasanna A, Whitell CW, Wu FY, Friedman DB, Arteaga CL. Convergence of p53 and transforming growth factor beta (TGF beta) signaling on activating expression of the tumor suppressor gene maspin in mammary epithelial cells. J Biol Chem 2007; 282:5661-9; PMID:17204482
   PubMed Web of Science ®Google Scholar
• Kunz C, Pebler S, Otte J, Vonderahe D. Differential regulation of plasminogen-activator and inhibitor gene-transcription by the tumor-suppressor P53. Nucleic Acids Res 1995; 23:3710-7; PMID:7479001
   PubMed Web of Science ®Google Scholar
• Velasco-Miguel S, Buckbinder L, Jean P, Gelbert L, Talbott R, Laidlaw J, Seizinger B, Kley N. PA26 a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes. Oncogene 1999; 18:127-37; PMID:9926927
   PubMed Web of Science ®Google Scholar
• Maiyar AC, Huang AJ, Phu PT, Cha HH, Firestone GL. p53 stimulates promoter activity of the sgk serumglucocorticoid-inducible serinethreonine protein kinase gene in rodent mammary epithelial cells. J Biol Chem 1996; 271:12414-22; PMID:8647846
   PubMed Web of Science ®Google Scholar
• Nagy N, Takahara M, Nishikawa J, Bourdon JC, Kis LL, Klein G, Klein E. Wild-type p53 activates SAP expression in lymphoid cells. Oncogene 2004; 23:8563-70; PMID:15378026
   PubMed Web of Science ®Google Scholar
• Fiucci G, Beaucourt S, Duflaut D, Lespagnol A, Stumptner-Cuvelette P, Géant A, Buchwalter G, Tuynder M, Susini L, Lassalle JM, et al. Siah-1b is a direct transcriptional target of p53: Identification of the functional p53 responsive element in the siah-1b promoter. Proc Nat Acad Sci USA 2004; 101:3510-5; PMID:14985507
   PubMed Web of Science ®Google Scholar
• Fortin A, MacLaurin JG, Arbour N, Cregan SP, Kushwaha N, Callaghan SM, Park DS, Albert PR, Slack RS. The proapoptotic gene SIVA is a direct transcriptional target for the tumor suppressors p53 and E2F1. J Biol Chem 2004; 279:28706-14; PMID:15105421
   PubMed Web of Science ®Google Scholar
• Anazawa Y, Arakawa H, Nakagawa H, Nakamura Y. Identification of STAG1 as a key mediator of a p53-dependent apoptotic pathway. Oncogene 2004; 23:7621-7; PMID:15361841
   PubMed Web of Science ®Google Scholar
• Zhang YH, Shu LM, Chen XB. Syntaxin 6 a regulator of the protein trafficking machinery and a target of the p53 family is required for cell adhesion and survival. J Biol Chem 2008; 283:30689-98; PMID:18779328; http://dx.doi.org/10.1074/jbc.M801711200
   PubMed Web of Science ®Google Scholar
• Kishore AH, Batta K, Das C, Agarwal S, Kundu TK. p53 regulates its own activator: transcriptional co-activator PC4 a new p53-responsive gene. Biochem J 2007; 406:437-44; PMID:17555406
   PubMed Web of Science ®Google Scholar
• da Costa NM, Hautefeuille A, Cros MP, Melendez ME, Waters T, Swann P, Hainaut P, Pinto LF. Transcriptional regulation of thymine DNA glycosylase (TDG) by the tumor suppressor protein p53. Cell Cycle 2012; 11:4570-8; PMID:23165212; http://dx.doi.org/10.4161/cc.22843
   PubMed Web of Science ®Google Scholar
• Li H, Watts GS, Oshiro MM, Futscher BW, Domann FE. AP-2 alpha and AP-2 gamma are transcriptional targets of p53 in human breast carcinoma cells. Oncogene 2006; 25 5405-15; PMID:16636674
   PubMed Web of Science ®Google Scholar
• Shin TH, Paterson AJ, Kudlow JE. P53 stimulates transcription from the human transforming growth-factor-alpha promoter - a potential growth-stimulatory role for P53. Mol Cell Biol 1995; 15:4694-701; PMID:7651386
   PubMed Web of Science ®Google Scholar
• Menendez D, Shatz M, Azzam K, Garantziotis S, Fessler MB, Resnick MA. The toll-like receptor gene family is integrated into human DNA damage and p53 networks. Plos Genetics 2011; 7(3):e1001360; PMID:21483755; http://dx.doi.org/10.1371/journal.pgen.1001360
   PubMedGoogle Scholar
• Taura M, Eguma A, Suico MA, Shuto T, Koga T, Komatsu K, Komune T, Sato T, Saya H, Li JD, et al. p53 Regulates toll-like receptor 3 expression and function in human epithelial cell Lines. Mol Cell Biol 2008; 28:6557-67; PMID:18779317; http://dx.doi.org/10.1128/MCB.01202-08
   PubMed Web of Science ®Google Scholar
• Liu XG, Yue P, Khuri FR, Sun SY. p53 upregulates death receptor 4 expression through an intronic p53 binding site. Cancer Res 2004; 64:5078-83; PMID:15289308
   PubMed Web of Science ®Google Scholar
• Takimoto R, el-Deiry WS. Wild-type p53 transactivates the KILLERDR5 gene through an intronic sequence-specific DNA-binding site. Oncogene 2000; 19:1735-43; PMID:10777207
   PubMed Web of Science ®Google Scholar
• Wang SL, el-Deiry WS. P73 or p53 directly regulates human p53 transcription to maintain cell cycle checkpoints. Cancer Res 2006; 66:6982-9; PMID:16849542
   PubMed Web of Science ®Google Scholar
• Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T, Nishimori H, Tamai K, Tokino T, Nakamura Y, et al. p53AlP1 a potential mediator of p53-dependent apoptosis and its regulation by Ser-46-phosphorylated p53. Cell 2000; 102:849-62; PMID:11030628
   PubMed Web of Science ®Google Scholar
• Contente A, Dittmer A, Koch MC, Roth J, Dobbelstein M. A polymorphic microsatellite that mediates induction of PIG3 by p53. Nat Genet 2002; 30:315-20; PMID:11919562
   PubMed Web of Science ®Google Scholar
• Okamura S, Arakawa H, Tanaka T, Nakanishi H, Ng CC, Taya Y, Monden M, Nakamura Y. p53DINP1 a p53-inducible gene regulates p53-dependent apoptosis. Molecular Cell 2001; 8:85-94; PMID:11511362
   PubMed Web of Science ®Google Scholar
• Harmes DC, Bresnick E, Lubin EA, Watson JK, Heim KE, Curtin JC, Suskind AM, Lamb J, DiRenzo J. Positive and negative regulation of Delta N-p63 promoter activity by p53 and Delta N-p63-alpha contributes to differential regulation of p53 target genes. Oncogene 2003; 22:7607-16; PMID:14576823
   PubMed Web of Science ®Google Scholar
• Chen XB, Zheng YM, Zhu JH, Jiang JY, Wang J. p73 is transcriptionally regulated by DNA damage p53 and p73. Oncogene 2001; 20:769-74; PMID:11314010
   PubMed Web of Science ®Google Scholar
• Kartasheva NN, Contente A, Lenz-Stoppler C, Roth J, Dobbelstein M. p53 induces the expression of its antagonist p73 Delta N establishing an autoregulatory feedback loop. Oncogene 2002; 21:4715-27; PMID:12101410
   PubMed Web of Science ®Google Scholar
• Wang JL, Liu YX, Hande MP, Wong AC, Jin YJ, Yin Y. TAp73 is a downstream target of p53 in controlling the cellular defense against stress. J Biol Chem 2007; 282:29152-62; PMID:17693405
   PubMed Web of Science ®Google Scholar
• Park WR, Nakamura Y. p53CSV a novel p53-inducible gene involved in the p53-dependent cell-survival pathway. Cancer Res 2005; 65:1197-206; PMID:15735003
   PubMed Web of Science ®Google Scholar
• Obad S, Brunnström H, Vallon-Christersson J, Borg A, Drott K, Gullberg U. Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells. Oncogene 2004; 23:4050-9; PMID:15064739
   PubMed Web of Science ®Google Scholar
• Nylander K, Bourdon JC, Bray SE, Gibbs NK, Kay R, Hart I, Hall PA. Transcriptional activation of tyrosinase and TRP-I by p53 links UV irradiation to the protective tanning response. J Pathol 2000; 190:39-46; PMID:10640990
   PubMed Web of Science ®Google Scholar
• Miyamoto Y, Futamura M, Kitamura N, Nakamura Y, Baba H, Arakawa H. Identification of UNC5A as a novel transcriptional target of tumor suppressor p53 and a regulator of apoptosis. Int J Oncol 2010; 36 1253-60; PMID:20372800
   PubMed Web of Science ®Google Scholar
• Yoon H, Liyanarachchi S, Wright FA, Davuluri R, Lockman JC, de la Chapelle A, Pellegata NS. Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53. Proc Natl Acad Sci USA 2002; 99:15632-7; PMID:12438652
   PubMed Web of Science ®Google Scholar
• Maruyama R, Aoki F, Toyota M, Sasaki Y, Akashi H, Mita H, Suzuki H, Akino K, Ohe-Toyota M, Maruyama Y, et al. Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation. Cancer Res 2006; 66:4574-83; PMID:16651407
   PubMed Web of Science ®Google Scholar
• Adimoolam S, Ford JM. p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene. Proc Natl Acad Sci USA 2002; 99:12985-90; PMID:12242345
   PubMed Web of Science ®Google Scholar
• Lee JY, Kim HJ, Yoon NA, Lee WH, Min YJ, Ko BK, Lee BJ, Lee A, Cha HJ, Cho WJ, et al. Tumor suppressor p53 plays a key role in induction of both tristetraprolin and let-7 in human cancer cells. Nucleic Acids Res 2013; 41:5614-25; PMID:23595149; http://dx.doi.org/10.1093/nar/gkt222.
   PubMed Web of Science ®Google Scholar
• Wilhelm MT, Mendez-Vidal C, Wiman KG. Identification of functional p53-binding motifs in the mouse wig-1 promoter. Febs Lett 2002; 524:69-72; PMID:12135743
   PubMed Web of Science ®Google Scholar
• Nishimori H, Shiratsuchi T, Urano T, Kimura Y, Kiyono K, Tatsumi K, Yoshida S, Ono M, Kuwano M, Nakamura Y, et al. A novel brain-specific p53-target gene BAI1 containing thrombospondin type 1 repeats inhibits experimental angiogenesis. Oncogene 1997; 15:2145-50; PMID:9393972
   PubMed Web of Science ®Google Scholar
• Ellisen LW, Ramsayer KD, Johannessen CM, Yang A, Beppu H, Minda K, Oliner JD, McKeon F, Haber DA. REDD1 a evelopmentally regulated transcriptional target of p63 and p53 links p63 to regulation of reactive oxygen species. Mol Cell 2002; 10:995-1005; PMID:12453409
   PubMed Web of Science ®Google Scholar
• Kimura Y, Furuhata T, Urano T, Hirata K, Nakamura Y, Tokino T. Genomic structure and chromosomal localization of GML (GPI-anchored molecule-like protein) a gene induced by p53. Genomics 1997; 41:477-80; PMID:9169150
   PubMed Web of Science ®Google Scholar
• Metcalfe AM, Dixon RM, Radda GK, Wild-type but not mutant p53 activates the hepatocyte growth factorscatter factor promoter. Nucleic Acids Res. 1997; 25:983-6; PMID:9023107
   PubMed Web of Science ®Google Scholar
• Kato MV, Sato H, Nagayoshi M, Ikawa Y. Upregulation of the elongation factor-1alpha gene by p53 in association with death of an erythroleukemic cell line. Blood 1997; 90:1373-8; PMID:9269753
   PubMed Web of Science ®Google Scholar
• Scherer SJ, Maier SM, Seifert M, Hanselmann RG, Zang KD, Muller-Hermelink HK, Angel P, Welter C, Schartl M. p53 and c-Jun functionally synergize in the regulation of the DNA repair gene hMSH2 in response to UV. J Biol Chem 2000; 275:37469-73; PMID:10984493
   PubMed Web of Science ®Google Scholar
• Warnick CT, Dabbas B, Ford CD, Strait KA. Identification of a p53 response element in the promoter region of the hMSH2 gene required for expression in A2780 ovarian cancer cells. J Biol Chem 2001; 276:27363-70; PMID:11350971
   PubMed Web of Science ®Google Scholar
• Urano T, Nishimori H, Han H, Furuhata T, Kimura Y, Nakamura Y, Tokino T. Cloning of P2XM a novel human P2X receptor gene regulated by p53. Cancer Res 1997; 57:3281-7; PMID:9242461
   PubMed Web of Science ®Google Scholar
• Dornan D, Bheddah S, Newton K, Ince W, Frantz GD, Dowd P, Koeppen H, Dixit VM, French DM. COP1 the negative regulator of p53 is overexpressed in breast and ovarian adenocarcinomas. Cancer Res 2004; 64:7226-30; PMID:15492238
   PubMed Web of Science ®Google Scholar
• Han HJ, Tokino T, Nakamura Y. CSR a scavenger receptor-like protein with a protective role against cellular damage causedby UV irradiation and oxidative stress. Hum Mol Genet 1998; 7:1039-46; PMID:9580669
   PubMed Web of Science ®Google Scholar
• Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S, Kinzler KW, Vogelstein B. 14-3-3 sigma is a p53-regulated inhibitor of G2M progression. Mol Cell 1997; 1:3-11; PMID:9659898
   PubMed Web of Science ®Google Scholar
• Passer BJ, Nancy-Portebois V, Amzallag N, Prieur S, Cans C, Roborel de Climens A, Fiucci G, Bouvard V, Tuynder M, Susini L, et al. The p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase. Proc Natl Acad Sci USA 2003; 100:2284-9; PMID:12606722
   PubMed Web of Science ®Google Scholar
• Herzer K, Falk CS, Encke J, Eichhorst ST, Ulsenheimer A, Seliger B, Krammer PH. Upregulation of major histocompatibility complex class I on liver cells by hepatitis C virus core protein via p53 and TAP1 impairs natural killer cell cytotoxicity. J Virol 2003; 77:8299-309; PMID:12857899
   PubMed Web of Science ®Google Scholar
• Johnson RA, Ince TA, Scotto KW. Transcriptional repression by p53 through direct binding to a novel DNA element. J Biol Chem 2001; 276:27716-20; PMID:11350951
   PubMed Web of Science ®Google Scholar
• Lee KC, Crowe AJ, Barton MC. p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding. Mol. Cell Biol 1999; 19:1279-88; PMID:9891062
   PubMed Web of Science ®Google Scholar
• Ogden SK, Lee KC, Wernke-Dollries K, Stratton SA, Aronow B, Barton MC. p53 targets chromatin structure alteration to repress alpha-fetoprotein gene expression. J Biol Chem 2001; 276:42057-62; PMID:11572852
   PubMed Web of Science ®Google Scholar
• Nguyen TT, Cho K, Stratton SA, Barton MC. Transcription factor interactions and chromatin modifications associated with p53-mediated, developmental repression of the alpha-fetoprotein gene. Mol Cell Biol 2005; 25:2147-57; PMID:15743813
   PubMed Web of Science ®Google Scholar
• Tsai WW, Nguyen TT, Shi Y, Barton MC. P53-targeted LSD1 functions in repression of chromatin structure and transcription in vivo. Mol Cell Biol 2008; 28:5139-46; PMID:18573881; http://dx.doi.org/10.1128/MCB.00287-08
   PubMed Web of Science ®Google Scholar
• Mirza A, Wu Q, Wang L, McClanahan T, Bishop WR, Gheyas F, Ding W, Hutchins B, Hockenberry T, Kirschmeier P, et al. Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression. Oncogene 2003; 22:3645-54; PMID:12789273
   PubMed Web of Science ®Google Scholar
• Zaky A, Busso C, Izumi T, Chattopadhyay R, Bassiouny A, Mitra S, Bhakat KK. Regulation of the human AP-endonuclease (APE1Ref-1) expression by the tumor suppressor p53 in response to DNA damage. Nucleic Acids Res 2008; 36:1555-66; PMID:18208837; http://dx.doi.org/10.1093/nar/gkm1173
   PubMed Web of Science ®Google Scholar
• Alimirah F, Panchanathan R, Chen J, Zhang X, Ho SM, Choubey D. Expression of androgen receptor is negatively regulated by p53. Neoplasia 2007; 9:1152-9; PMID:18084622
   PubMed Web of Science ®Google Scholar
• Ceribelli M, Alcalay M, Vigano MA, Mantovani R. Repression of new p53 targets revealed by ChIP on chip experiments. Cell Cycle 2006; 5:1102-10; PMID:16721047
   PubMed Web of Science ®Google Scholar
• Budhram-Mahadeo V, Morris PJ, Smith MD, Midgley CA, Boxer LM, Latchman DS. p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor. J Biol Chem 1999; 274:15237-44; PMID:10329733
   PubMed Web of Science ®Google Scholar
• Wu Y, Mehew JW, Heckman CA, Arcinas M, Boxer LM, Negative regulation of bcl-2 expression by p53 in hematopoietic cells. Oncogene 2001; 20:240-51; PMID:11313951
   PubMed Web of Science ®Google Scholar
• Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 2002; 277:3247-57; PMID:11714700
   PubMed Web of Science ®Google Scholar
• Esteve PO, Chin HG, Pradhan S. Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters. Proc Natl Acad Sci USA 2005; 102:1000-5; PMID:15657147
   PubMed Web of Science ®Google Scholar
• Raj D, Liu T, Samadashwily G, Li F, Grossman D. Survivin repression by p53 Rb and E2F2 in normal human melanocytes. Carcinogenesis 2008; 29:194-201; PMID:17916908
   PubMed Web of Science ®Google Scholar
• Nabilsi NH, Broaddus RR, Loose DS. DNA methylation inhibits p53-mediated survivin repression. Oncogene 2009; 28:2046-50; PMID:19363521; http://dx.doi.org/10.1038/onc.2009.62
   PubMed Web of Science ®Google Scholar
• Zalcenstein A, Weisz L, Stambolsky P, Bar J, Rotter V, Oren M. epression of the MSPMST-1 gene contributes to the antiapoptotic gain of function of mutant p53. Oncogene 2006; 25:359-69; PMID:16170349
   PubMed Web of Science ®Google Scholar
• Feng X, Liu X, Zhang W, Xiao W.H. p53 directly suppresses BNIP3 expression to protect against hypoxia-induced cell death. Embo Journal 2011; 30:3397-415; PMID:21792176; http://dx.doi.org/10.1038/emboj.2011.248
   PubMed Web of Science ®Google Scholar
• Jin W, Chen Y, Di GH, Miron P, Hou YF, Gao H, Shao ZM. Estrogen Receptor (ER)beta or p53 Attenuates ER alpha-mediated Transcriptional Activation on the BRCA2 Promoter. J Biol Chem 2008; 283:29671-80; PMID:18765668; http://dx.doi.org/10.1074/jbc.M802785200
   PubMed Web of Science ®Google Scholar
• Innocente SA, Lee JM. p53 is a NF-Y- and p21-independent Sp1-dependent repressor of cyclin B1 transcription. Febs Lett. 2005; 579:1001-7; PMID:15710382
   PubMed Web of Science ®Google Scholar
• Lipski R, Lippincott DJ, Durden BC, Kaplan AR, Keiser HE, Park JH, Levesque AA. p53 Dimers associate with a head-to-tail response element to repress cyclin B transcription. PLoS One 2012; 7(8):e42615; PMID:22905155; http://dx.doi.org/10.1371/journal.pone.0042615
   PubMedGoogle Scholar
• Imbriano C, Gurtner A, Cocchiarella F, Di Agostino S, Basile V, Gostissa M, Dobbelstein M, Del Sal G, Piaggio G, Mantovani R. Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2M promoters. Mol Cell Biol 2005; 25:3737-51; PMID:15831478
   PubMed Web of Science ®Google Scholar
• Dalvai M, Mondesert O, Bourdon JC, Ducommun B, Dozier C. Cdc25B is negatively regulated by p53 through Sp1 and NF-Y transcription factors. Oncogene 2011; 30:2282-8; PMID:21242964; http://dx.doi.org/10.1038/onc.2010.588
   PubMed Web of Science ®Google Scholar
• St.Clair S, Giono L, Varmeh-Ziaie S, Resnick-Silverman L, Liu WJ, Padi A, Dastidar J, DaCosta A, Mattia M, Manfredi JJ. DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: one involves direct binding to the cdc25C promoter. Mol Cell 2004; 16:725-36; PMID:15574328
   PubMed Web of Science ®Google Scholar
• Le Gac G, Esteve PO, Ferec C, Pradhan S. DNA damage-induced down-regulation of human Cdc25C and Cdc2 is mediated by cooperation between p53 and maintenance DNA (cytosine-5) methyltransferase 1. J Biol Chem 2006; 281:24161-70; PMID:16807237
   PubMed Web of Science ®Google Scholar
• Zeng YX, Kotake Y, Pei XH, Smith MD, Xiong Y. p53 Binds to and Is Required for the Repression of Arf Tumor Suppressor by HDAC and Polycomb. Cancer Res 2011; 71:2781-92; PMID:21447739; http://dx.doi.org/10.1158/0008-5472.CAN-10-3483
   PubMed Web of Science ®Google Scholar
• Bansal N, Kadamb R, Mittal S, Vig L, Sharma R, Dwarakanath BS, Saluja D. Tumor Suppressor Protein p53 Recruits Human Sin3BHDAC1 Complex for Down-Regulation of Its Target Promoters in Response to Genotoxic Stress. PLoS One 2011; 6(10):e26156; PMID:22028823; http://dx.doi.org/10.1371/journal.pone.0026156
   PubMedGoogle Scholar
• Banerjee T, Nath S, Roychoudhury S. DNA damage induced p53 downregulates Cdc20 by direct binding to its promoter causing chromatin remodeling. Nucleic Acids Res 2009; 37:2688-98; PMID:19273532; http://dx.doi.org/10.1093/nar/gkp110
   PubMed Web of Science ®Google Scholar
• Godar S, Ince TA, Bell GW, Feldser D, Donaher JL, Bergh J, Liu A, Miu K, Watnick RS, Reinhardt F, et al. Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression. Cell 2008; 134:62-73; PMID:18614011; http://dx.doi.org/10.1016/j.cell.2008.06.006
   PubMed Web of Science ®Google Scholar
• Yang MZ, Yuan F, Li P, Chen Z, Chen A, Li S, Hu C. Interferon regulatory factor 4 binding protein is a novel p53 target gene and suppresses cisplatininduced apoptosis of breast cancer cells. Mol Cancer 2012; 11:54; PMID:22888789
   PubMed Web of Science ®Google Scholar
• Kho PS, Wang Z, Zhuang L, Li Y, Chew JL, Ng HH, Liu ET, Yu Q. p53-regulated transcriptional program associated with genotoxic stress-induced apoptosis. J Biol Chem 2004; 279:21183-92; PMID:15016801
   PubMed Web of Science ®Google Scholar
• Peterson EJ, Bogler O, Taylor SM. p53-mediated repression of DNA methyltransferase 1 expression by specific DNA binding. Cancer Res 2003; 63:6579-82; PMID:14583449
   PubMed Web of Science ®Google Scholar
• Lin RK, Wu CY, Chang JW, Juan LJ, Hsu HS, Chen CY, Lu YY, Tang YA, Yang YC, Yang PC, et al. Dysregulation of p53Sp1 Control Leads to DNA Methyltransferase-1 Overexpression in Lung Cancer. Cancer Res 2010; 70:5807-17; PMID:20570896; http://dx.doi.org/10.1158/0008-5472.CAN-09-4161
   PubMed Web of Science ®Google Scholar
• Wilson PM, Fazzone W, LaBonte MJ, Lenz HJ, Ladner RD. Regulation of human dUTPase gene expression and p53-mediated transcriptional repression in response to oxaliplatin-induced DNA damage. Nucleic Acids Res 2009; 37:78-95; PMID:19015155; http://dx.doi.org/10.1093/nar/gkn910
   PubMed Web of Science ®Google Scholar
• Scoumanne A, Chen XB, The epithelial cell transforming sequence 2, a guanine nucleotide exchange factor for Rho GTPases is repressed by p53 via protein methyltransferases and is required for G(1)-S transition. Cancer Res 2006; 66:6271-9; PMID:16778203
   PubMed Web of Science ®Google Scholar
• Sankpal NV, Willman MW, Fleming TP, Mayfield JD, Gillanders WE. Transcriptional Repression of Epithelial Cell Adhesion Molecule Contributes to p53 Control of Breast Cancer Invasion. Cancer Res 2009; 69:753-7; PMID:19141643; http://dx.doi.org/10.1158/0008-5472.CAN-08-2708
   PubMed Web of Science ®Google Scholar
• Salah Z, Haupt S, Maoz M, Baraz L, Rotter V, Peretz T, Haupt Y, Bar-Shavit R. p53 controls hPar1 function and expression. Oncogene 2008; 27:6866-74; PMID:18820708; http://dx.doi.org/10.1038/onc.2008.324
   PubMed Web of Science ®Google Scholar
• Wong J, Li PX, Klamut HJ. A novel p53 transcriptional repressor element (p53TRE) and the asymmetrical contribution of two p53 binding sites modulate the response of the placental transforming growth factor-beta promoter to p53. J Biol Chem 2002; 277:26699-707; PMID:12011055
   PubMed Web of Science ®Google Scholar
• Du P, Tang FQ, Qiu YL, Dong F. GFI1 is repressed by p53 and inhibits DNA damage-induced apoptosis. PLoS One 2013; 8(9):e73542; PMID:24023884; http://dx.doi.org/10.1371/journal.pone.0073542
   PubMedGoogle Scholar
• Maeda Y, Hwang-Verslues WW, Wei G, Fukazawa T, Durbin ML, Owen LB, Liu X, Sladek FM. Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4alpha (HNF4alpha) gene. Biochem J 2006; 400:303-13; PMID:16895524
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang JS, Chen LL, Zhang Y, Cheng XK, Heng FY, Wu NH, Shen YF. Repression of hsp90 beta gene by p53 in UV irradiation-induced apoptosis of Jurkat cells. J Biol Chem 2004; 279:42545-51; PMID:15284248
   PubMed Web of Science ®Google Scholar
• Paolella BR, Havrda MC, Mantani A, Wray CM, Zhang Z, Israel MA. p53 Directly represses id2 to inhibit the proliferation of neural progenitor cells. Stem Cells 2011; 29:1090-101; PMID:21608079; http://dx.doi.org/10.1002/stem.660
   PubMed Web of Science ®Google Scholar
• Im HJ, Pittelkow MR, Kumar R. Divergent regulation of the growth-promoting gene IEX-1 by the p53 tumor suppressor and Sp1. J Biol Chem 2002; 277:14612-21; PMID:11844788
   PubMed Web of Science ®Google Scholar
• Werner H, Karnieli E, Rauscher FJ, LeRoith D. Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc Natl Acad Sci USA 1996; 93:8318-23; PMID:8710868
   PubMed Web of Science ®Google Scholar
• Kavurma MM, Figg N, Bennett MR, Mercer J, Khachigian LM, Littlewood TD. Oxidative stress regulates IGF1R expression in vascular smooth-muscle cells via p53 and HDAC recruitment. Biochem J 2007; 407:79-87; PMID:17600529
   PubMed Web of Science ®Google Scholar
• Zhang LJ, Kashanchi F, Zhan Q, Zhan S, Brady JN, Fornace AJ, Seth P, Helman LJ. Regulation of insulin-like growth factor II p3 promoter by p53: A potential mechanism for tumorigenesis. Cancer Res 1996; 56 1367-73; PMID:8640827
   PubMed Web of Science ®Google Scholar
• Cai BH, Hsu PC, Hsin IL, Chao CF, Lu MH, Lin HC, Chiou SH, Tao PL, Chen JY. p53 Acts as a Co-Repressor to Regulate Keratin 14 Expression during Epidermal Cell Differentiation. PLoS One 2012; 7(7):e41742; PMID:22911849; http://dx.doi.org/10.1371/journal.pone.0041742
   PubMedGoogle Scholar
• Wang B, Feng P, Xiao ZW, Ren EC. LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinoma. J Hepatol 2009; 50:528-37; PMID:19155088; http://dx.doi.org/10.1016/j.jhep.2008.10.025
   PubMed Web of Science ®Google Scholar
• Cecchinelli B, Lavra L, Rinaldo C, Iacovelli S, Gurtner A, Gasbarri A, Ulivieri A, Del Prete F, Trovato M, Piaggio G, et al. Repression of the antiapoptotic molecule galectin-3 by homeodomain-interacting protein kinase 2-activated p53 is required for p53-induced apoptosis. Mol Cell Biol 2006; 26:4746-57; PMID:16738336
   PubMed Web of Science ®Google Scholar
• Chun AC, Jin DY. Transcriptional regulation of mitotic checkpoint gene MAD1 by p53. J. Biol. Chem 2003; 278:37439-50; PMID:12876282
   PubMed Web of Science ®Google Scholar
• Murphy M, Ahn J, Walker KK, Hoffman WH, Evans RM, Levine AJ, George DL. Transcriptional repression by wild-type p53 utilizes histone deacetylases mediated by interaction with mSin3a. Genes Dev 1999; 13:2490-501; PMID:10521394
   PubMed Web of Science ®Google Scholar
• Jiang P, Du WJ, Mancuso A, Wellen KE, Yang XL. Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence. Nature 2013; 493(7434):689-93; PMID:23334421; http://dx.doi.org/10.1038/nature11776
   PubMed Web of Science ®Google Scholar
• Lee MH, Na H, Kim EJ, Lee HW, Lee MO. Poly(ADP-ribosyl)ation of p53 induces gene-specific transcriptional repression of MTA1. Oncogene 2012; 31:5099-107; PMID:22286760; http://dx.doi.org/10.1038/onc.2012.2
   PubMed Web of Science ®Google Scholar
• Ho JS, Ma W, Mao DY, Benchimol S. p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest. Mol. Cell Biol 2005; 25:7423-31; PMID:16107691
   PubMed Web of Science ®Google Scholar
• Lin TX, Chao C, Saito S, Mazur SJ, Murphy ME, Appella E, Xu Y. P53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 2005; 7:165-U80; PMID:15619621
   PubMed Web of Science ®Google Scholar
• Nabilsi NH, Ryder DJ, Peraza-Penton AC, Poudyal R, Loose DS, Kladde MP. Local Depletion of DNA Methylation Identifies a Repressive p53 Regulatory Region in the NEK2 Promoter. J Biol Chem 2013; 288:35940-51; PMID:24163369; http://dx.doi.org/10.1074/jbc.M113.523837
   PubMed Web of Science ®Google Scholar
• Li YZ, Lu DY, Tan WQ, Wang JX, Li PF. p53 initiates apoptosis by transcriptionally targeting the antiapoptotic protein ARC. Mol. Cell Biol 2008; 28:564-74; PMID:17998337
   PubMed Web of Science ®Google Scholar
• Mortensen K, Skouv J, Hougaard DM, Larsson LI. Endogenous endothelial cell nitric-oxide synthase modulates apoptosis in cultured breast cancer cells and is transcriptionally regulated by p53. J Biol Chem 1999; 274:37679-84; PMID:10608825
   PubMed Web of Science ®Google Scholar
• Saifudeen Z, Marks J, Du H, El-Dahr SS. Spatial repression of PCNA by p53 during kidney development. Am J Physiol Renal Physiol 2002; 283:F727-33; PMID:12217864
   PubMedGoogle Scholar
• Astanehe A, Arenillas D, Wasserman WW, Leung PC, Dunn SE, Davies BR, Mills GB, Auersperg N. Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer. J Cell Sci 2008; 121:664-74; PMID:18270270; http://dx.doi.org/10.1242/jcs.013029
   PubMed Web of Science ®Google Scholar
• McKenzie L, King S, Marcar L, Nicol S, Dias SS, Schumm K, Robertson P, Bourdon JC, Perkins N, Fuller-Pace F, et al. p53-dependent repression of polo-like kinase-1 (PLK1;. Cell Cycle 2010; 9:4200-12; PMID:20962589
   PubMed Web of Science ®Google Scholar
• Zhou Z, Cao JX, Li SY, An GS, Ni JH, Jia HT. p53 Suppresses E2F1-dependent PLK1 expression upon DNA damage by forming p53-E2F1-DNA complex. Exp Cell Res 2013; 319:3104-15; PMID:24076372; http://dx.doi.org/10.1016/j.yexcr.2013.09.012
   PubMed Web of Science ®Google Scholar
• Van Bodegom D, Saifudeen Z, Dipp S, Puri S, Magenheimer BS, Calvet JP, El-Dahr SS. The polycystic kidney disease-1 gene is a target for p53-mediated transcriptional repression. J Biol Chem 2006; 281:31234-44; PMID:16931520
   PubMed Web of Science ®Google Scholar
• Van Bodegom D, Roessingh W, Pridjian A, El Dahr SS. Mechanisms of p53-mediated repression of the human polycystic kidney disease-1 promoter. Biochim Biophys Acta 2010; 1799:502-09; PMID:20388565
   PubMed Web of Science ®Google Scholar
• Islam MR, Jimenez T, Pelham C, Rodova M, Puri S, Magenheimer BS, Maser RL, Widmann C, Calvet JP. MAPERK Kinase Kinase 1 (MEKK1) Mediates Transcriptional Repression by Interacting with Polycystic Kidney Disease-1 (PKD1) Promoter-bound p53 Tumor Suppressor Protein. J Biol Chem 2010; 285:38818-31.
   PubMed Web of Science ®Google Scholar
• Li BQ ,Lee MYW Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1. J Biol Chem 2001; 276:29729-39; PMID:11375983
   PubMed Web of Science ®Google Scholar
• Sahin E, Colla S, Liesa M, Moslehi J, Müller FL, Guo M, Cooper M, Kotton D, Fabian AJ, Walkey C, et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 2011; 470:359-65; PMID:21307849; http://dx.doi.org/10.1038/nature09787
   PubMed Web of Science ®Google Scholar
• Li C, Lin M, Liu J. Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis. Oncogene 2004; 23:9336-47; PMID:15531928; http://dx.doi.org/10.1038/sj.onc.1208114
   PubMed Web of Science ®Google Scholar
• Hsieh WJ, Hsieh SC, Chen CC, Wang FF. Human DDA3 is an oncoprotein down-regulated by p53 and DNA damage. Biochem Biophys Res Commun 2008; 369:567-72; PMID:10196169; http://dx.doi.org/10.1016/j.bbrc.2008.02.047
   PubMed Web of Science ®Google Scholar
• Subbaramaiah K, Altorki N, Chung WJ, Mestre JR, Sampat A, Dannenberg AJ. Inhibition of cyclooxygenase-2 gene expression by p53. J. Biol. Chem 1999; 274:10911-5; PMID:10196169; http://dx.doi.org/10.1074/jbc.274.16.10911
   PubMed Web of Science ®Google Scholar
• Montano X. Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation. Oncogene 2009; 28:3787-800; PMID:19749791; http://dx.doi.org/10.1038/onc.2009.143
   PubMed Web of Science ®Google Scholar
• Golubovskaya V, Kaur A, Cance W. Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites. B B A-Gene Struct Expr 2004; 1678:111-25; http://dx.doi.org/10.1016/j.bbaexp.2004.03.002
   PubMed Web of Science ®Google Scholar
• Golubovskaya VM, Finch R, Kweh F, Massoll NA, Campbell-Thompson M, Wallace MR, Cance WG. P53 regulates FAK expression in human tumor cells. Mol Carcinogen 2008; 47:373-82; PMID:17999388; http://dx.doi.org/10.1002/mc.20395
   PubMed Web of Science ®Google Scholar
• Arias-Lopez C, Lazaro-Trueba I, Kerr P, Lord CJ, Dexter T, Iravani M, Ashworth A, Silva A. p53 modulates homologous recombination by transcriptional regulation of the RAD51 gene. EMBO Rep 2006; 7:219-24; PMID:16322760; http://dx.doi.org/10.1038/sj.embor.7400587
   PubMed Web of Science ®Google Scholar
• Osifchin NE, Jiang D, Ohtani-Fujita N, Fujita T, Carroza M, Kim SJ, Sakai T, Robbins PD. Identification of A P53 Binding-Site in the Human Retinoblastoma Susceptibility Gene Promoter. J Biol Chem 1994; 269:6383-9.380; PMID:8119988
   PubMedGoogle Scholar
• Sengupta S, Shimamoto A, Koshiji M, Pedeux R, Rusin M, Spillare EA, Shen JC, Huang LE, Lindor NM, Furuichi Y, et al. Tumor suppressor p53 represses transcription of RECQ4 helicase. Oncogene 2005; 24:1738-48; PMID:15674334; http://dx.doi.org/10.1038/sj.onc.1208380
   PubMed Web of Science ®Google Scholar
• Farkas C, Martins CP, Escobar D, Hepp MI, Donner DB, Castro AF, Evan G, Gutiérrez JL, Warren R, Pincheira R. Wild Type p53 Transcriptionally Represses the SALL2 Transcription Factor under Genotoxic Stress. PLoS One 2013; 8:e73817; PMID:24040083; http://dx.doi.org/10.1371/journal.pone.0073817
   PubMedGoogle Scholar
• Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res 2004; 64:2627-33; PMID:15059920; http://dx.doi.org/10.1158/0008-5472.CAN-03-0846
   PubMed Web of Science ®Google Scholar
• Han XB, Patters AB, Chesney RW. Transcriptional repression of taurine transporter gene (TauT) by p53 in renal cells. J Biol Chem 2002; 277:39266-73; PMID:12163498; http://dx.doi.org/10.1074/jbc.M205939200
   PubMed Web of Science ®Google Scholar
• Faraonio R, Vergara P, Di Marzo D, Pierantoni MG, Napolitano M, Russo T, Cimino F. p53 suppresses the Nrf2-dependent transcription of antioxidant response genes. J Biol Chem 2006; 281:39776-84; PMID:17077087; http://dx.doi.org/10.1074/jbc.M605707200
   PubMed Web of Science ®Google Scholar
• Dhar SK, Xu Y, Chen YM, Clair DKS. Specificity protein 1-dependent p53-mediated suppression of human manganese superoxide dismutase gene expression. J Biol Chem 2006; 281:21698-709; PMID:16740634; http://dx.doi.org/10.1074/jbc.M601083200
   PubMed Web of Science ®Google Scholar
• Dhar SK, Xu Y, St Clair DK. Nuclear Factor kappa B- and Specificity Protein 1-dependent p53-mediated Bi-directional Regulation of the Human Manganese Superoxide Dismutase Gene. J Biol Chem 2010; 285:9835-46; PMID:20061391; http://dx.doi.org/10.1074/jbc.M109.060715
   PubMed Web of Science ®Google Scholar
• Dhar SK, Tangpong J, Chaiswing L, Oberley TD, St Clair DK. Manganese Superoxide Dismutase Is a p53-Regulated Gene That Switches Cancers between Early and Advanced Stages. Cancer Res 2011; 71:6684-95; PMID:22009531; http://dx.doi.org/10.1158/0008-5472.CAN-11-1233
   PubMed Web of Science ®Google Scholar
• Kim E, Günther W, Yoshizato K, Meissner H, Zapf S, Nüsing RM, Yamamoto H, Van Meir EG, Deppert W, Giese A. Tumor suppressor p53 inhibits transcriptional activation of invasion gene thromboxane synthase mediated by the proto-oncogenic factor ets-1. Oncogene 2003; 22:7716-27; PMID:14586398; http://dx.doi.org/10.1038/sj.onc.1207155
   PubMed Web of Science ®Google Scholar
• Tu SP, Chi AL, Ai W, Takaishi S, Dubeykovskaya Z, Quante M, Fox JG, Wang TC. p53 inhibition of AP1-dependent TFF2 expression induces apoptosis and inhibits cell migration in gastric cancer cells. A J Physiol-Gast L Phys 2009; 297:G385-96; PMID:19541923
   PubMed Web of Science ®Google Scholar
• D’Souza S, Xin H, Walter S, Choubey D. The gene encoding p202 an interferon-inducible negative regulator of the p53 tumor suppressor is a target of p53-mediated transcriptional repression. J. Biol. Chem 2001; 276:298-305; PMID:11013253; http://dx.doi.org/10.1074/jbc.M007155200
   PubMed Web of Science ®Google Scholar
• Amson R, Pece S, Lespagnol A, Vyas R, Mazzarol G, Tosoni D, Colaluca I, Viale G, Rodrigues-Ferreira S, Wynendaele J, et al. Reciprocal repression between P53 and TCTP. Nat. Med 2011; 18:91-9; PMID:22157679; http://dx.doi.org/10.1038/nm.2546
   PubMed Web of Science ®Google Scholar
• Zhang DW, Jeang KT, Lee CGL. p53 negatively regulates the expression of FAT10 a gene upregulated in various cancers. Oncogene 2006; 25:2318-27; PMID:16501612; http://dx.doi.org/10.1038/sj.onc.1209220
   PubMed Web of Science ®Google Scholar
• van der Watt PJ, Leaner VD. The nuclear exporter Crm1 is regulated by NFY and Sp1 in cancer cells and repressed by p53 in response to DNA damage. BiochimBioph Acta-Gene Regul Mech 2011; 1809:316-26.
   Web of Science ®Google Scholar
• Radhakrishnan VM, Putnam CW, Qi WQ, Martinez JD. P53 suppresses expression of the 14-3-3gamma oncogene. Bmc Cancer 2011; 11; PMID:21791091; http://dx.doi.org/10.1186/1471-2407-11-378
   PubMed Web of Science ®Google Scholar
• Yan HL, Xue G, Mei Q, Wang YZ, Ding FX, Liu MF, Lu MH, Tang Y, Yu HY, Sun SH. Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis. EMBO J 2009; 28:2719-32; PMID:19696742; http://dx.doi.org/10.1038/emboj.2009.214
   PubMed Web of Science ®Google Scholar
• Johnson RA, Ince TA, Scotto KW. Transcriptional repression by p53 through direct binding a novel DNA element. J Biol Chem 2001; 276:27716-20; PMID:11350951; http://dx.doi.org/10.1074/jbc.C100121200
   PubMed Web of Science ®Google Scholar
• Budhram-Mahadeo V, Morris PJ, Smith MD, Midgley CA, Boxer LM, Latchman DS. p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor. J Biol Chem 1999; 274:15237-44; PMID:10329733; http://dx.doi.org/10.1074/jbc.274.21.15237
   PubMed Web of Science ®Google Scholar
• Innocente SA, Lee JM. P53 is a NF-Y- and p21-independent Sp1-dependent repressor of cyclin B1 transcription. Febs Lett 2005; 579:1001-7; PMID:15710382; http://dx.doi.org/10.1016/j.febslet.2004.12.073
   PubMed Web of Science ®Google Scholar
• Banerjee T, Nath S, Roychoudhury S. DNA damage induced p53 downregulates Cdc20 by direct binding to its promoter causing chromatin remodeling. Nucleic Acids Res 2009; 37:2688-98; PMID:19273532; http://dx.doi.org/10.1093/nar/gkp110
   PubMed Web of Science ®Google Scholar
• Chun ACS, Jin DY. Transcriptional regulation of mitotic checkpoint gene MAD1 by p53. J Biol Chem 2003; 278:37439-50; PMID:12876282; http://dx.doi.org/10.1074/jbc.M307185200
   PubMed Web of Science ®Google Scholar
• de Toledo SM, Azzam EI, Keng P, Laffrenier S, Little JB. Regulation by ionizing radiation of CDC2 cyclin A cyclin B thymidine kinase topoisomerase IIalpha and RAD51 expression in normal human diploid fibroblasts is dependent on p53p21Waf1. Cell Growth Differ 1998; 9:887-96; PMID:9831241
   PubMedGoogle Scholar
• Chang BD, Watanabe K, Broude EV, Fang J, Poole JC, Kalinichenko TV, Roninson IB. Effects of p21(Waf1Cip1Sdi1) on cellular gene expression: Implications for carcinogenesis senescence and age-related diseases. Proc Natl Acad Sci USA 2000; 97:4291-6.
   PubMed Web of Science ®Google Scholar
• Flatt PM, Tang LJ, Scatena CD, Szak ST, Pietenpol JA. p53 regulation of G(2) checkpoint is retinoblastoma protein dependent. Mol Cell Biol 2000; 20:4210-23; PMID:10825186; http://dx.doi.org/10.1128/MCB.20.12.4210-4223.2000
   PubMed Web of Science ®Google Scholar
• Löhr K, Möritz C, Contente A, Dobbelstein M. p21CDKN1A mediates negative regulation of transcription by p53. J Biol Chem 2003; 278:32507-16; PMID:12748190
   PubMed Web of Science ®Google Scholar
• Tabach Y, Milyavsky M, Shats I, Brosh R, Zuk O, Yitzhaky A, Mantovani R, Domany E, Rotter V, Pilpel Y. The promoters of human cell cycle genes integrate signals from two tumor suppressive pathways during cellular transformation. Mol Syst Biol 2005; 1:2005; PMID:16729057
   PubMed Web of Science ®Google Scholar
• Jackson MW, Agarwal MK, Yang J, Bruss P, Uchiumi T, Agarwal ML, Stark GR, Taylor WR. p130p107p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2. J Cell Sci 2005; 118:1821-32; PMID:15827088; http://dx.doi.org/10.1242/jcs.02307
   PubMed Web of Science ®Google Scholar
• Ginsberg D, Mechta F, Yaniv M, Oren M, Wild-type p53 can down-modulate the activity of various promoters. Proc Natl Acad Sci USA 1991; 88:9979-83; PMID:1946467; http://dx.doi.org/10.1073/pnas.88.22.9979
   PubMed Web of Science ®Google Scholar
• Wang B, Xiao ZW, Ren EC. Redefining the p53 response element. Proc Natl Acad Sci USA 2009; 106:14373-8; PMID:19597154
   PubMed Web of Science ®Google Scholar
• Imbriano C, Gnesutta N, Mantovani R. The NF-Yp53 liaison: Well beyond repression. Biochim Biophys Acta 2012; 1825:131-9; PMID:22138487
   PubMed Web of Science ®Google Scholar
• Chen X, Müller GA, Quaas M, Fischer M, Han N, Stutchbury B, Sharrocks AD, Engeland K. The forkhead transcription factor FOXM1 controls cell cycle-dependent gene expression through an atypical chromatin binding mechanism. Mol Cell Biol 2013; 33:227-36; PMID:23109430; http://dx.doi.org/10.1128/MCB.00881-12
   PubMed Web of Science ®Google Scholar
• Chicas A, Wang X, Zhang C, McCurrach M, Zhao Z, Mert O, Dickins RA, Narita M, Zhang M, Lowe SW. Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence. Cancer Cell 2010; 17:376-87; PMID:20385362; http://dx.doi.org/10.1016/j.ccr.2010.01.023
   PubMed Web of Science ®Google Scholar
• Litovchick L, Sadasivam S, Florens L, Zhu X, Swanson SK, Velmurugan S, Chen R, Washburn MP, Liu XS, DeCaprio JA. Evolutionarily conserved multisubunit RBL2p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence. Mol. Cell 2007; 26:539-51; PMID:17531812; http://dx.doi.org/10.1016/j.molcel.2007.04.015
   PubMed Web of Science ®Google Scholar
• Sadasivam S, Duan S, DeCaprio JA. The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression. Genes Dev 2012; 26:474-89; PMID:22391450; http://dx.doi.org/10.1101/gad.181933.111
   PubMed Web of Science ®Google Scholar
• Resnick-Silverman L, St Clair S, Maurer M, Zhao K, Manfredi JJ. Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53. Genes Dev 1998; 12:2102-7; PMID:9679054; http://dx.doi.org/10.1101/gad.12.14.2102
   PubMed Web of Science ®Google Scholar
• Krause K, Haugwitz U, Wasner M, Wiedmann M, Mössner J, Engeland K. Expression of the cell cycle phosphatase cdc25C is down-regulated by the tumour suppressor protein p53 but not by p73. Biochem Biophys Res Commun 2001; 284:743-50; PMID:11396965; http://dx.doi.org/10.1006/bbrc.2001.5040
   PubMed Web of Science ®Google Scholar
• Benson EK, et al. p53-dependent gene repression through p21 is mediated by recruitment of E2F4 repression complexes. Oncogene 2014; 33:3959-69;http://dx.doi.org/10.1038/onc.2013.378
   PubMed Web of Science ®Google Scholar
• Spitkovsky D, Schulze A, Boye B, Jansen-Durr P, Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter. Cell Growth Differ 1997; 8:699-710; PMID:9186003
   PubMedGoogle Scholar
• Azzam EI, deToledo SM, Pykett MJ, Nagasawa H, Little JB. CDC2 is down-regulated by ionizing radiation in a p53-dependent manner. Cell Growth Differ 1997; 8:1161-9.
   PubMedGoogle Scholar
• Gottifredi V, Karni-Schmidt O, Shieh SS, Prives C. p53 down-regulates CHK1 through p21 and the retinoblastoma protein. Mol Cell Biol 2001; 21:1066-76; PMID:11158294; http://dx.doi.org/10.1128/MCB.21.4.1066-1076.2001
   PubMed Web of Science ®Google Scholar
• Zhu H, Chang BD, Uchiumi T, Roninson IB. Identification of promoter elements responsible for transcriptional inhibition of polo-like kinase 1 and topoisomerase IIalpha genes by p21(WAF1CIP1SDI1. Cell Cycle 2002; 1:59-66; PMID:12429910
   PubMed Web of Science ®Google Scholar
• Shats I, Milyavsky M, Tang X, Stambolsky P, Erez N, Brosh R, Kogan I, Braunstein I, Tzukerman M, Ginsberg D, et al. p53-dependent down-regulation of telomerase is mediated by p21waf1. J Biol Chem 2004; 279:50976-85; PMID:15371422; http://dx.doi.org/10.1074/jbc.M402502200
   PubMed Web of Science ®Google Scholar
• Jackson JG, Pereira-Smith OM. Primary and compensatory roles for RB family members at cell cycle gene promoters that are deacetylated and downregulated in doxorubicin-induced senescence of breast cancer cells. Mol Cell Biol 2006; 26:2501-10; PMID:16537896; http://dx.doi.org/10.1128/MCB.26.7.2501-2510.2006
   PubMed Web of Science ®Google Scholar
• Barsotti AM, Prives C. Pro-proliferative FoxM1 is a target of p53-mediated repression. Oncogene 2009; 28:4295-305; PMID:19749794; http://dx.doi.org/10.1038/onc.2009.282
   PubMed Web of Science ®Google Scholar
• Schvartzman JM, Duijf PH, Sotillo R, Coker C, Benezra R. Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition. Cancer Cell 2011; 19:701-14; PMID:21665145; http://dx.doi.org/10.1016/j.ccr.2011.04.017
   PubMed Web of Science ®Google Scholar
• Mannefeld M, Klassen E, Gaubatz S. B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells. Cancer Res 2009; 69:4073-80; PMID:19383908; http://dx.doi.org/10.1158/0008-5472.CAN-08-4156
   PubMed Web of Science ®Google Scholar
• Quaas M, Müller GA, Engeland K. p53 can repress transcription of cell cycle genes through a p21(WAF1CIP1)-dependent switch from MMB to DREAM protein complex binding at CHR promoter elements. Cell Cycle 2012; 11:4661-72; PMID:23187802; http://dx.doi.org/10.4161/cc.22917
   PubMed Web of Science ®Google Scholar
• Fischer M, Grundke I, Sohr S, Quaas M, Hoffmann S, Knörck A, Gumhold C, Rother K. p53 and cell cycle dependent transcription of kinesin family member 23 (KIF23) is controlled via a CHR promoter element bound by DREAM and MMB complexes. PLoS One 2013; 8:e63187; PMID:23650552; http://dx.doi.org/10.1371/journal.pone.0063187
   PubMed Web of Science ®Google Scholar
• Fischer M, Quaas M, Wintsche A, Müller GA, Engeland K. Polo-like kinase 4 transcription is activated via CRE and NRF1 elements repressed by DREAM through CDECHR sites and deregulated by HPV E7 protein. Nucleic Acids Res 2014; 42:163-80; PMID:24071582; http://dx.doi.org/10.1093/nar/gkt849
   PubMed Web of Science ®Google Scholar
• Schmit F, Korenjak M, Mannefeld M, Schmitt K, Franke C, von Eyss B, Gagrica S, Hänel F, Brehm A, Gaubatz S. LINC a human complex that is related to pRB-containing complexes in invertebrates regulates the expression of G2M genes. Cell Cycle 2007; 6:1903-13; PMID:17671431; http://dx.doi.org/10.4161/cc.6.15.4512
   PubMed Web of Science ®Google Scholar
• Sadasivam S, DeCaprio JA. The DREAM complex: master coordinator of cell cycle-dependent gene expression. Nat. Rev. Cancer 2013; 13:585-95; PMID:23842645; http://dx.doi.org/10.1038/nrc3556
   PubMed Web of Science ®Google Scholar
• Taylor WR, Schonthal AH, Galante J, Stark GR. p130E2F4 binds to and represses the cdc2 promoter in response to p53. J Biol Chem 2001; 276:1998-2006; PMID:11032828; http://dx.doi.org/10.1074/jbc.M005101200
   PubMed Web of Science ®Google Scholar
• Scian MJ, Carchman EH, Mohanraj L, Stagliano KE, Anderson MA, Deb D, Crane BM, Kiyono T, Windle B, Deb SP, et al. Wild-type p53 and p73 negatively regulate expression of proliferation related genes. Oncogene 2008; 27:2583-93; PMID:17982488; http://dx.doi.org/10.1038/sj.onc.1210898
   PubMed Web of Science ®Google Scholar
• Desdouets C, Ory C, Matesic G, Soussi T, Bréchot C, Sobczak-Thépot J. ATF/CREB site mediated transcriptional activation and p53 dependent repression of the cyclin A promoter. Febs Lett 1996; 385:34-8; PMID:8641461; http://dx.doi.org/10.1016/0014-5793(96)00330-4
   PubMed Web of Science ®Google Scholar
• Kidokoro T, Tanikawa C, Furukawa Y, Katagiri T, Nakamura Y, Matsuda K. CDC20 a potential cancer therapeutic target is negatively regulated by p53. Oncogene 2008; 27:1562-71; PMID:17873905; http://dx.doi.org/10.1038/sj.onc.1210799
   PubMed Web of Science ®Google Scholar
• Badie C, Bourhis J, Sobczak-Thépot J, Haddada H, Chiron M, Janicot M, Janot F, Tursz T, Vassal G. p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line. Br J Cancer 2000; 82:642-50; PMID:10682678
   PubMed Web of Science ®Google Scholar
• Tang X, Milyavsky M, Shats I, Erez N, Goldfinger N, Rotter V. Activated p53 suppresses the histone methyltransferase EZH2 gene. Oncogene 2004; PMID:15208672; 23:5759-69; http://dx.doi.org/10.1038/sj.onc.1207706
   PubMed Web of Science ®Google Scholar
• Moberg KH, Tyndall WA, Hall DJ. Wild-type murine p53 represses transcription from the murine c-myc promoter in a human glial cell line. J Cell Biochem 1992; 49:208-15; PMID:1400626; http://dx.doi.org/10.1002/jcb.240490213
   PubMed Web of Science ®Google Scholar
• Mungamuri SK, Benson EK, Wang S, Gu W, Lee SW, Aaronson SA. p53-mediated heterochromatin reorganization regulates its cell fate decisions. Nat Struct Mol Biol 2012; 19:478-84 S1; PMID:22466965; http://dx.doi.org/10.1038/nsmb.2271
   PubMed Web of Science ®Google Scholar
• Krause K, Wasner M, Reinhard W, Haugwitz U, Dohna CL, Mössner J, Engeland K. The tumour suppressor protein p53 can repress transcription of cyclin B. Nucleic Acids Res 2000; 28:4410-8; PMID:11071927; http://dx.doi.org/10.1093/nar/28.22.4410
   PubMed Web of Science ®Google Scholar
• Rother K, Kirschner R, Sänger K, Böhlig L, Mössner J, Engeland K. p53 downregulates expression of the G(1)S cell cycle phosphatase Cdc25A. Oncogene 2007; 26:1949-53; PMID:17001315; http://dx.doi.org/10.1038/sj.onc.1209989
   PubMed Web of Science ®Google Scholar
• Rother K, Dengl M, Lorenz J, Tschöp K, Kirschner R, Mössner J, Engeland K. Gene expression of cyclin-dependent kinase subunit Cks2 is repressed by the tumor suppressor p53 but not by the related proteins p63 or p73. Febs Lett 2007; 581:1166-72; PMID:17336302; http://dx.doi.org/10.1016/j.febslet.2007.02.028
   PubMed Web of Science ®Google Scholar
• Rother K, Li YY, Tschöp K, Kirschner R, Müller GA, Mössner J, Engeland K. Expression of cyclin-dependent kinase subunit 1 (Cks1) is regulated during the cell cycle by a CDECHR Tandem element and is downregulated by p53 but not by p63 or p73. Cell Cycle 2007; 6:853-62; PMID:17377499; http://dx.doi.org/10.4161/cc.6.7.4017
   PubMed Web of Science ®Google Scholar
• Dobbelstein M. Interchanging heads: p53 re-composes the DREAMMMB complex to repress transcription. Cell Cycle 2013; 12:11; PMID:23255095; http://dx.doi.org/10.4161/cc.23169
   PubMed Web of Science ®Google Scholar
• Westendorp B, Mokry M, Groot Koerkamp MJ, Holstege FC, Cuppen E, de Bruin A. E2F7 represses a network of oscillating cell cycle genes to control S-phase progression. Nucleic Acids Res 2012; 40:3511-23; PMID:22180533; http://dx.doi.org/10.1093/nar/gkr1203
   PubMed Web of Science ®Google Scholar
• Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 2010; 10:550-60; PMID:20592731; http://dx.doi.org/10.1038/nrc2886
   PubMed Web of Science ®Google Scholar
• Dyson N, Howley PM, Munger K, Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 243:934-7; PMID:2537532; http://dx.doi.org/10.1126/science.2537532
   PubMed Web of Science ®Google Scholar
• Nor Rashid N, Yusof R, Watson RJ. Disruption of repressive p130-DREAM complexes by human papillomavirus 16 E6E7 oncoproteins is required for cell-cycle progression in cervical cancer cells. J Gen Virol 2011; 92:2620-7; PMID:21813705; http://dx.doi.org/10.1099/vir.0.035352-0
   PubMed Web of Science ®Google Scholar
• Mack DH, Vartikar J, Pipas JM, Laimins L. A. Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53. Nature 1993; 363:281-3; PMID:8387645; http://dx.doi.org/10.1038/363281a0
   PubMed Web of Science ®Google Scholar
• Shaulian E, Haviv I, Shaul Y, Oren M. Transcriptional repression by the C-terminal domain of p53. Oncogene 1995; 10:671-80; PMID:7862444
   PubMed Web of Science ®Google Scholar
• Agoff SN, Hou J, Linzer DI, Wu B. Regulation of the human hsp70 promoter by p53. Science 1993; 259:84-7; PMID:8418500; http://dx.doi.org/10.1126/science.8418500
   PubMed Web of Science ®Google Scholar
• Kubicka S, Kühnel F, Zender L, Rudolph KL, Plümpe J, Manns M, Trautwein C. p53 represses CAAT enhancer-binding protein (CEBP)-dependent transcription of the albumin gene. A molecular mechanism involved in viral liver infection with implications for hepatocarcinogenesis. J Biol Chem 1999; 274:32137-44; PMID:10542249; http://dx.doi.org/10.1074/jbc.274.45.32137
   PubMed Web of Science ®Google Scholar
• Esteve PO, Chin HG, Pradhan S. Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells. J Biol Chem 2007; 282:2615-25; PMID:17124180; http://dx.doi.org/10.1074/jbc.M606203200
   PubMed Web of Science ®Google Scholar
• Chun JY, Hu Y, Pinder E, Wu J, Li F, Gao AC. Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter. Mol Cancer Ther 2007; 6:2572-80; PMID:17876054; http://dx.doi.org/10.1158/1535-7163.MCT-07-0172
   PubMed Web of Science ®Google Scholar
• Wu K, Jiang SW, Couch FJ. p53 mediates repression of the BRCA2 promoter and down-regulation of BRCA2 mRNA and protein levels in response to DNA damage. J Biol Chem 2003; 278:15652-60; PMID:12591928; http://dx.doi.org/10.1074/jbc.M211297200
   PubMed Web of Science ®Google Scholar
• Manni I, Mazzaro G, Gurtner A, Mantovani R, Haugwitz U, Krause K, Engeland K, Sacchi A, Soddu S, Piaggio G. NF-Y mediates the transcriptional inhibition of the cyclin B1 cyclin B2 and cdc25C promoters upon induced G2 arrest. J Biol Chem 2001; 276:5570-6; PMID:11096075; http://dx.doi.org/10.1074/jbc.M006052200
   PubMed Web of Science ®Google Scholar
• Matsui T, Katsuno Y, Inoue T, Fujita F, Joh T, Niida H, Murakami H, Itoh M, Nakanishi M. Negative regulation of Chk2 expression by p53 is dependent on the CCAAT-binding transcription factor NF-Y. J Biol Chem 2004; 279:25093-100; PMID:15044452; http://dx.doi.org/10.1074/jbc.M403232200
   PubMed Web of Science ®Google Scholar
• Gu L, Zhu N, Findley HW, Woods WG, Zhou M. Identification and characterization of the IKKalpha promoter: positive and negative regulation by ETS-1 and p53 respectively. J Biol Chem 2004; 279:52141-9; PMID:15469934; http://dx.doi.org/10.1074/jbc.M407915200
   PubMed Web of Science ®Google Scholar
• Elias A, Wu J, Chen T. Tumor suppressor protein p53 negatively regulates human pregnane X receptor activity. Mol Pharmacol 2013; 83:1229-36; PMID:23536728; http://dx.doi.org/10.1124/mol.113.085092
   PubMed Web of Science ®Google Scholar
• Zhu N, Gu L, Findley HW, Zhou M. Transcriptional repression of the eukaryotic initiation factor 4E gene by wild type p53. Biochem Biophys Res Commun 2005; 335:1272-9; PMID:16112647; http://dx.doi.org/10.1016/j.bbrc.2005.08.026
   PubMed Web of Science ®Google Scholar
• Faniello MC, Di Sanzo M, Quaresima B, Baudi F, Di Caro V, Cuda G, Morrone G, Del Sal G, Spinelli G, Venuta S, et al. p53-mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y. Int J Biochem Cell Biol 2008; 40:2110-9; PMID:18372207; http://dx.doi.org/10.1016/j.biocel.2008.02.010
   PubMed Web of Science ®Google Scholar
• Webster NJ, Resnik JL, Reichart DB, Strauss B, Haas M, Seely BL. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer. Cancer Res 1996; 56:2781-8; PMID:8665514
   PubMed Web of Science ®Google Scholar
• Lin YC, Chen YN, Lin KF, Wang FF, Chou TY, Chen MY. Association of p21 with NF-YA suppresses the expression of Polo-like kinase 1 and prevents mitotic death in response to DNA damage. Cell Death Dis 2014; 5:e987; PMID:24407240; http://dx.doi.org/10.1038/cddis.2013.527
   PubMedGoogle Scholar
• Zhan M, Yu D, Liu J, Glazer RI, Hannay J, Pollock RE. Transcriptional repression of protein kinase Calpha via Sp1 by wild type p53 is involved in inhibition of multidrug resistance 1 P-glycoprotein phosphorylation. J Biol Chem 2005; 280:4825-33; PMID:15563462; http://dx.doi.org/10.1074/jbc.M407450200
   PubMed Web of Science ®Google Scholar
• Zhou Y, Mehta KR, Choi AP, Scolavino S, Zhang X. DNA damage-induced inhibition of securin expression is mediated by p53. J Biol Chem 2003; 278:462-70; PMID:12403781
   PubMed Web of Science ®Google Scholar
• Modugno M, Tagliabue E, Ardini E, Berno V, Galmozzi E, De Bortoli M, Castronovo V, Ménard S. p53-dependent downregulation of metastasis-associated laminin receptor. Oncogene 2002; 21:7478-87; PMID:12386810; http://dx.doi.org/10.1038/sj.onc.1205957
   PubMed Web of Science ®Google Scholar
• Xu D, Wang Q, Gruber A, Björkholm M, Chen Z, Zaid A, Selivanova G, Peterson C, Wiman KG, Pisa P. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells. Oncogene 2000; 19:5123-33; PMID:11064449; http://dx.doi.org/10.1038/sj.onc.1203890
   PubMed Web of Science ®Google Scholar
• Kanaya T, Kyo S, Hamada K, Takakura M, Kitagawa Y, Harada H, Inoue M. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription. Clin Cancer Res 2000; 6:1239-47; PMID:10778946
   PubMed Web of Science ®Google Scholar
• Joshi AA, Wu Z, Reed RF, Suttle DP. Nuclear factor-Y binding to the topoisomerase IIalpha promoter is inhibited by both the p53 tumor suppressor and anticancer drugs. Mol Pharmaco 2003;. 63:359-67; PMID:12527807; http://dx.doi.org/10.1124/mol.63.2.359
   PubMed Web of Science ®Google Scholar
• Pal S, Datta K, Mukhopadhyay D. Central role of p53 on regulation of vascular permeability factorvascular endothelial growth factor (VPFVEGF) expression in mammary carcinoma. Cancer Res 2001; 61:6952-7; PMID:11559575
   PubMed Web of Science ®Google Scholar
• Yamabe Y, Shimamoto A, Goto M, Yokota J, Sugawara M, Furuichi Y. Sp1-mediated transcription of the Werner helicase gene is modulated by Rb and p53. Mol Cell Biol 1998; 18:6191-200.PMID:9774636
   PubMed Web of Science ®Google Scholar
• Yap N, Yu CL, Cheng SY Modulation of the transcriptional activity of thyroid hormone receptors by the tumor suppressor p53. Proc Natl Acad Sci USA 1996; 93:4273-7; PMID:8633054; http://dx.doi.org/10.1073/pnas.93.9.4273
   PubMed Web of Science ®Google Scholar
• Taura M, Suico MA, Fukuda R, Koga T, Shuto T, Sato T, Morino-Koga S, Okada S, Kai H. MEFELF4 transactivation by E2F1 is inhibited by p53. Nucleic Acids Res 2011; 39:76-88; PMID:20805247; http://dx.doi.org/10.1093/nar/gkq762
   PubMed Web of Science ®Google Scholar
• Tophkhane C, Yang SH, Jiang Y, Ma Z, Subramaniam D, Anant S, Yogosawa S, Sakai T, Liu WG, Edgerton S, et al. p53 inactivation upregulates p73 expression through E2F-1 mediated transcription. PLoS One 2012; 7:e43564; PMID:22952705; http://dx.doi.org/10.1371/journal.pone.0043564
   PubMedGoogle Scholar
• Yun J, Chae HD, Choy HE, Chung J, Yoo HS, Han MH, Shin DY. p53 negatively regulates cdc2 transcription via the CCAAT- binding NF-Y transcription factor. J Biol Chem 1999; 274:29677-82; PMID:10514438; http://dx.doi.org/10.1074/jbc.274.42.29677
   PubMed Web of Science ®Google Scholar
• Salsi V, Caretti G, Wasner M, Reinhard W, Haugwitz U, Engeland K, Mantovani R. Interactions between p300 and multiple NF-Y trimers govern Cyclin B2 promoter function. J Biol Chem 2003; 278:6642-50; PMID:12482752; http://dx.doi.org/10.1074/jbc.M210065200
   PubMed Web of Science ®Google Scholar
• Müller GA, Engeland K. The central role of CDECHR promoter elements in the regulation of cell cycle-dependent gene transcription. FEBS J 2010; 277:877-93; PMID:20015071
   PubMed Web of Science ®Google Scholar
• Kasowski M, Grubert F, Heffelfinger C, Hariharan M, Asabere A, Waszak SM, Habegger L, Rozowsky J, Shi M, Urban AE, et al. Variation in transcription factor binding among humans. Science 2010; 328:232-5; PMID:20299548; http://dx.doi.org/10.1126/science.1183621
   PubMed Web of Science ®Google Scholar
• (a) Zwicker J, Lucibello FC, Wolfraim LA, Gross C, Truss M, Engeland K, Müller R. Cell cycle regulation of the cyclin A cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression. EMBO J 1995; 14:4514-22; PMID:7556094; (b) Müller GA, Wintsche A, Stangner K, Prohaska SJ, Stadler PF, Engeland K. The CHR site: Definition and genome-wide identification of a cell cycle transcriptional element. Nucl Acids Res. 2014; PMID:25106871; http://dx.doi.org/10.1093/nar/gku696
   PubMed Web of Science ®Google Scholar
• Müller GA, Quaas M, Schümann M, Krause E, Padi M, Fischer M, Litovchick L, DeCaprio JA, Engeland K. The CHR promoter element controls cell cycle-dependent gene transcription and binds the DREAM and MMB complexes. Nucleic Acids Res 2012; 40:1561-78; PMID:22064854; http://dx.doi.org/10.1093/nar/gkr793
   PubMed Web of Science ®Google Scholar
• Yang J, Song K, Krebs TL, Jackson MW, Danielpour D. RbE2F4 and Smad23 link survivin to TGF-beta-induced apoptosis and tumor progression. Oncogene 2008; 27:5326-38; PMID:18504435; http://dx.doi.org/10.1038/onc.2008.165
   PubMed Web of Science ®Google Scholar
• Yee AS, Reichel R, Kovesdi I, Nevins JR. Promoter interaction of the E1A-inducible factor E2F and its potential role in the formation of a multi-component complex. EMBO J 1987; 6:2061-8; PMID:2820719
   PubMed Web of Science ®Google Scholar
• Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR. The E2F transcription factor is a cellular target for the RB protein. Cell 1991; 65:1053-61; PMID:1828392; http://dx.doi.org/10.1016/0092-8674(91)90557-F
   PubMed Web of Science ®Google Scholar
• Wells J, Yan PS, Cechvala M, Huang T, Farnham PJ. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase. Oncogene 2003; 22:1445-60; PMID:12629508; http://dx.doi.org/10.1038/sj.onc.1206264
   PubMed Web of Science ®Google Scholar
• Elkon R, Linhart C, Sharan R, Shamir R, Shiloh Y. Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells. Genome Res 2003; 13:773-80; PMID:12727897; http://dx.doi.org/10.1101/gr.947203
   PubMed Web of Science ®Google Scholar
• Linhart C, Elkon R, Shiloh Y, Shamir R, Deciphering transcriptional regulatory elements that encode specific cell cycle phasing by comparative genomics analysis. Cell Cycle 2005; 4:1788-97; PMID:16294034; http://dx.doi.org/10.4161/cc.4.12.2173
   PubMed Web of Science ®Google Scholar
• Suzuki H, Forrest AR, van Nimwegen E, Daub CO, Balwierz PJ, Irvine KM, Lassmann T, Ravasi T, Hasegawa Y, de Hoon MJ, et al. The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line. Nat Genet 2009; 41:553-62; PMID:19377474; http://dx.doi.org/10.1038/ng.375
   PubMed Web of Science ®Google Scholar
• He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, et al. A microRNA component of the p53 tumour suppressor network. Nature 2007; 447:1130-4; PMID:17554337; http://dx.doi.org/10.1038/nature05939
   PubMed Web of Science ®Google Scholar
• Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M, et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 2010; 142:409-19; PMID:20673990; http://dx.doi.org/10.1016/j.cell.2010.06.040
   PubMed Web of Science ®Google Scholar
• Hung T, Wang Y, Lin MF, Koegel AK, Kotake Y, Grant GD, Horlings HM, Shah N, Umbricht C, Wang P, et al. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet 2011; 43:621-9; PMID:21642992; http://dx.doi.org/10.1038/ng.848
   PubMed Web of Science ®Google Scholar
• Hwang CI, Matoso A, Corney DC, Flesken-Nikitin A, Körner S, Wang W, Boccaccio C, Thorgeirsson SS, Comoglio PM, Hermeking H, et al. Wild-type p53 controls cell motility and invasion by dual regulation of MET expression. Proc Natl Acad Sci USA 2011; 108:14240-5; PMID:21831840; http://dx.doi.org/10.1073/pnas.1017536108
   PubMed Web of Science ®Google Scholar
• Concepcion CP, Han YC, Mu P, Bonetti C, Yao E, D'Andrea A, Vidigal JA, Maughan WP, Ogrodowski P, Ventura A. Intact p53-dependent responses in miR-34-deficient mice. PLoS Genet 2012; 8:e1002797; PMID:22844244; http://dx.doi.org/10.1371/journal.pgen.1002797
   PubMed Web of Science ®Google Scholar
• Dimitrova N, Zamudio JR, Jong RM, Soukup D, Resnick R, Sarma K, Ward AJ, Raj A, Lee JT, Sharp PA, et al. LincRNA-p21 Activates p21 In cis to Promote Polycomb Target Gene Expression and to Enforce the G1S Checkpoint. Mol Cell 2014; 54:777-90; PMID:24857549; http://dx.doi.org/10.1016/j.molcel.2014.04.025
   PubMed Web of Science ®Google Scholar
• Benatti P, Dolfini D, Viganò A, Ravo M, Weisz A, Imbriano C. Specific inhibition of NF-Y subunits triggers different cell proliferation defects. Nucleic Acids Res 2011; 39:5356-68; PMID:21415014; http://dx.doi.org/10.1093/nar/gkr128
   PubMed Web of Science ®Google Scholar
• Meyer LR, Zweig AS, Hinrichs AS, Karolchik D, Kuhn RM, Wong M, Sloan CA, Rosenbloom KR, Roe G, Rhead B, et al. The UCSC Genome Browser database: extensions and updates 2013. Nucleic Acids Res 2013; 41:D64-9; PMID:23155063; http://dx.doi.org/10.1093/nar/gks1048
   PubMed Web of Science ®Google Scholar
• Flicek P, Ahmed I, Amode MR, Barrell D, Beal K, Brent S, Carvalho-Silva D, Clapham P, Coates G, Fairley S, et al. Ensembl 2013. Nucleic Acids Res 2013; 41:D48-55; PMID:23203987; http://dx.doi.org/10.1093/nar/gks1236
   PubMed Web of Science ®Google Scholar
• Quinlan AR, Hall IM, BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 2010; 26:841-2; PMID:20110278; http://dx.doi.org/10.1093/bioinformatics/btq033
   PubMed Web of Science ®Google Scholar
• Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, Rosenbloom K, Clawson H, Spieth J, Hillier LW, Richards S, et al. Evolutionarily conserved elements in vertebrate insect worm and yeast genomes. Genome Res 2005; 15:1034-50; PMID:16024819; http://dx.doi.org/10.1101/gr.3715005
   PubMed Web of Science ®Google Scholar
• Blanchette M, Kent WJ, Riemer C, Elnitski L, Smit AF, Roskin KM, Baertsch R, Rosenbloom K, Clawson H, Green ED, et al. Aligning multiple genomic sequences with the threaded blockset aligner. Genome Res 2004; 14:708-15; PMID:15060014; http://dx.doi.org/10.1101/gr.1933104
   PubMed Web of Science ®Google Scholar
• Wang B, Xiao Z, Ko HL, Ren EC. The p53 response element and transcriptional repression. Cell Cycle 2010; 9:870-9; PMID:20160511; http://dx.doi.org/10.4161/cc.9.5.10825
   PubMed Web of Science ®Google Scholar